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ABSTRACT 
Erica Jania Washington: Characterization of the role of Pseudomonas syringae type III 
effector HopAF1 in virulence 
(Under the direction of Jeff Dangl) 
 
Many plant pathogens, including Pseudomonas syringae, encode the type III 
secretion system for translocating effector proteins into the host during infection. Strains of 
P. syringae which are not capable of delivering the type III effectors are nonpathogenic. 
Therefore, the functions of type III effectors are essential for disease. Although several type 
III effectors have been demonstrated to block components of the plant defense response, 
the functions of most type III effectors are unknown. Our lab is interested in the type III 
effector HopAF1, a type III effector that is present in eleven of the nineteen sequenced 
strains of P. syringae and other plant pathogens. Although the presence of HopAF1 in 
multiple strains of P. syringae suggests that it plays an important role in virulence, no 
function has yet been associated with HopAF1. We generated a tertiary structural prediction 
for HopAF1, which suggests that HopAF1 is structurally related to bacterial deamidases. 
Deamidation, the irreversible substitution of an amide group with a carboxylate group, is the 
mechanism by which several bacterial virulence factors manipulate the activity of a specific 
substrate. To identify a potential target of HopAF1 activity, we employed a yeast two-hybrid 
screen and identified Arabidopsis methylthioadenosine nucleosidase (MTN1) as a putative 
target of HopAF1. This interaction, which we extended to include Arabidopsis MTN2, was 
confirmed in planta using coimmunoprecipitations and bimolecular fluorescence 
complementation assays. MTNs are enzymes in the Yang cycle, a cycle essential for high 
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levels of ethylene biosynthesis. Ethylene is a key plant hormone for plant developmental 
processes, such as senescence and flowering. Ethylene is also induced during PTI. 
Therefore, we hypothesized that HopAF1 inhibits PTI by manipulating MTNs and levels of 
ethylene in plants. To this end, we used gas chromatography to measure ethylene 
biosynthesis in plants treated with bacterially-delivered HopAF1. We determined that 
HopAF1 inhibits ethylene biosynthesis in a manner dependent on putative catalytic residues. 
Additionally, Yang cycle mutants mtn1 mtn2 and mtk are more susceptible to weak 
pathogens. This data is consistent with the idea that HopAF1 targets a novel component of 
the plant immune system, the Yang cycle.  
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 Chapter 1 
Introduction 
 
Plants constantly encounter pathogens such as insects, oomycetes, viruses, fungi, 
and bacteria in their natural habitats. However, many of these plant-microbe interactions do 
not result in disease. Plant species may be resistant to microbes that are successful 
pathogens on other plant species. This is called non-host resistance, and can be thought of 
as reflecting situations where the microbe in question is not evolutionarily adapted to life on 
that plant species (Senthil-Kumar and Mysore, 2013). Many mechanisms of non-host 
resistance involve physical barriers that prevent the pathogen from accessing nutrients in 
the plant apoplastic fluid. The waxy cuticle layer, the epidermis, and the plant cell wall are 
structural barriers common in many plants. Bacterial pathogens may access the apoplastic 
fluid through the stomatal openings in the plant leaf surface (Senthil-Kumar and Mysore, 
2013). However, another mechanism of non-host resistance is the closure of stomata in the 
presence of microbes (Melotto et al., 2006). Moreover, the presence of non-host microbes 
also induces reinforcements in the cell wall in the form of callose, lignin, or suberin near 
sites of infection (Senthil-Kumar and Mysore, 2013).   
Once microbes reach the apoplastic fluid, antimicrobials prevent further colonization. 
Non-host Arabidopsis apoplastic fluid extracts can restrict the growth of P. syringae 
pathovars (Senthil-Kumar and Mysore, 2013). However, P. syringae pathovars that are 
capable of causing disease in Arabidopsis are not inhibited by the apoplastic extracts (Fan 
et al., 2011). Some antimicrobials are constitutively produced, while others are induced by 
non-host microbes.  
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A two-tiered model of the plant innate immune system.  
Adapted microbes successful at surpassing the passive non-host immunity detailed 
above must overcome an active two-tiered plant immune system (Jones and Dangl, 2006). 
The first stage is PTI or PAMP-triggered immunity. As a key virulence strategy, pathogens 
have evolved effector molecules, such as type III effector (T3E) proteins in P. syringae and 
RXLR effectors in oomycetes, that target PTI, resulting in disease and effector-triggered 
susceptibility (ETS) (Jones and Dangl, 2006) (Table 1.1). Plants evolved the second tier of 
the immunity termed ETI for effector-triggered immunity. In ETI, plants use NLR (nucleotide-
binding domain and leucine-rich repeat-containing) proteins to detect effectors, often 
triggering a rapid and localized cell death response called HR.  
PAMP-triggered immunity 
The first line of active defense begins with transmembrane pattern recognition 
receptors (PRRs) recognizing conserved molecular patterns from pathogens called 
pathogen-associated molecular patterns or PAMPs (Boller and Felix, 2009). Since these 
microbial signatures are not limited to pathogenic microbes, they are perhaps more aptly 
referred to as microbial-associated molecular patterns or MAMPs. For the purposes of this 
introduction, we will use the terms PAMPs and PTI. PAMPs are often highly conserved 
across a wide range of microbes, fulfill a function essential to the pathogen’s lifecycle, and 
yet are not present in the host (Boller and Felix, 2009). Common bacterial PAMPs are 
lipopolysaccharide (LPS), peptidoglycan, elongation factor Tu (EF-Tu), and flagellin (Boller 
and Felix, 2009). Common fungal PAMPs include chitin and ergosterol, both derived from 
cell walls of fungi (Boller and Felix, 2009). A 22 amino acid peptide derived from a 
conserved region of the amino terminus of bacterial flagellin (flg22) and the first 18 amino 
acids of EF-Tu (elf18) are derivatives of flagellin and EF-Tu that are sufficient for recognition 
by host cell surface receptors (Felix et al., 1999; Kunze et al., 2004). 
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PAMP recognition occurs via pattern recognition receptors (PRRs) that are 
analogous to Toll-like receptors in animals. PRRs are either receptor-like kinases (RLKs) or 
receptor-like proteins (RLPs). RLKs contain an N-terminal extracellular domain, a single 
transmembrane domain, and a C-terminal kinase domain. RLPs contain an N-terminal 
extracellular domain, a single transmembrane domain, and a C-terminal short cytoplasmic 
tail. Some well-studied PRRs include FLS2, EFR, and CERK1 (Monaghan and Zipfel, 2012). 
FLS2 was the first PRR to be discovered and as a result, much of what we know about 
PAMP recognition stems from FLS2 studies (Gomez-Gomez and Boller, 2000). FLS2 is the 
RLK that recognizes flg22 (Gomez-Gomez and Boller, 2000). The C-terminal kinase domain 
of FLS2 is a Ser/Thr kinase, except that its catalytic loop contains a CD sequence instead of 
RD. For these reason, FLS2 is a non-RD kinase, which appears to be a hallmark of the 
kinase domain of immune system related PRRs (Dardick and Ronald, 2006). EFR is a 
Brassicaceae-specific RLK PRR that recognizes elf18 (Zipfel et al., 2006). CERK1, a RLK 
that recognizes fungal chitin and bacterial peptidoglycan in Arabidopsis, has three 
extracellular LysM domains for carbohydrate binding, along with the transmembrane domain 
and the C-terminal kinase domain (Miya et al., 2007; Wan et al., 2008). In rice, chitin 
recognition requires an additional RLP PRR called CeBiP (Kaku et al., 2006). CeBiP 
interacts with rice CERK1 and this interaction is enhanced in the presence of chitin (Shimizu 
et al., 2010).  
PAMP recognition and downstream signal transduction involve oligomerization of 
PRRs. BAK1 (BRI1-associated receptor kinase 1), a positive regulator of PTI signaling forms 
ligand-induced complexes with FLS2 and EFR (Chinchilla et al., 2007; Heese et al., 2007; 
Roux et al., 2011). This leads to the recruitment of several other RLKs, such as BIK1 and 
BKK1, to form heterocomplexes with EFR and FLS2 (Roux et al., 2011). BAK1 has been 
implicated in complex formation with multiple PRRs, such as PEPR1, an RLK that 
recognizes endogenous peptides, after induction with their cognate MAMPs (Schulze et al., 
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2010; Yamaguchi et al., 2006) Heterocomplex formation between the BAK1 and PRRs leads 
to trans-phosphorylation and signal transduction (Schulze et al., 2010). Schulze et al., 
demonstrated that triggering downstream flg22-mediated responses requires BAK1 with a 
functional kinase domain (Schulze et al., 2010). BAK1 is critical to PTI-related signaling 
because bak1 mutants have severely reduced responses to flg22 and are completely 
insensitive to elf18 (Chinchilla et al., 2007). BAK1 is also required for responses triggered by 
other PAMPs such as LPS and peptidoglycan (Shan et al., 2000). However, not all PTI 
signaling requires BAK1. For example, instead of interacting with BAK1, CERK1 undergoes 
ligand-induced homo-dimerization leading to activation of downstream immune responses 
(Liu et al., 2012). 
Perception of PAMPs triggers PTI (Jones and Dangl, 2006). PTI is a critical 
component of the two-tiered immune system because plants unable to trigger this response 
are more susceptible to infection. For example, Arabidopsis and N. benthamiana plants 
encoding a non-functional fls2 are more susceptible to bacterial infection (de Torres et al., 
2006; Hann and Rathjen, 2007; Li et al., 2005; Zipfel et al., 2004). Conversely, ectopic 
expression of EFR in non-Brassicaceae plants Nicotiana benthamiana and tomato increases 
their resistance to a range of bacterial pathogens (Lacombe et al., 2010).  
The timing of PTI responses after PAMP recognition ranges from seconds to hours. 
Early PTI responses include an influx in ions such as H+, K+, Cl- and Ca2+. Ca2+ activates 
calcium-dependent protein kinases and RbohD (Ma and Berkowitz, 2007). RbohD is a 
NADPH oxidase that contributes to reactive oxygen species (ROS) burst in Arabidopsis 
(Ogasawara et al., 2008). This ROS burst occurs approximately 2 minutes after PAMP 
recognition. ROS burst contributes to PTI by activating defense gene expression, 
strengthening the cell wall, and initiating cell death (Torres et al., 2006). PTI responses also 
include the activation of mitogen-activated kinases (MAPKs), which in turns leads to 
activation of the defense-related WRKY transcription factors (Asai et al., 2002). This is only 
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a fraction of the massive reprogramming of gene expression that occurs after PAMP 
recognition (Zipfel et al., 2006; Zipfel et al., 2004). Later PTI responses include the induction 
of ethylene biosynthesis and callose deposition. Callose deposition, an easily measured 
output and classic PTI response, consists of an accumulation of β-1,3-glucan polymers in 
the plant cell wall near the sight of infection to form physical barriers against further 
pathogen attack. We will address the role of ethylene further in the next section of this 
introduction.  
Effector-triggered immunity 
The second line of defense is the gene-for-gene recognition of pathogen effectors by 
plant disease resistance gene products. This line of defense evolved due to the ability of 
virulent pathogens to inhibit PTI and thus render the plant susceptible to infection. This 
condition is termed effector-triggered susceptibility or ETS (Jones and Dangl, 2006). Plants 
evolved disease resistance (R) proteins to combat ETS. Disease resistance proteins are 
often referred to as NB-LRR, or NLR, proteins due to their domain architecture, which 
consists of a central nucleotide-binding (NB) domain and highly polymorphic C-terminal LRR 
region. The N-terminal domains of NLRs commonly consist of either a TIR (Toll, interleukin-
1 receptor) domain or a CC (coiled-coil) domain. There are approximately 150 NLRs in the 
Arabidopsis Col-0 genome (Meyers et al., 2003).  
NLRs can detect effectors from a wide variety of plant pathogens including fungi, 
oomycetes, viruses, and bacteria. NLR proteins may detect effectors directly or indirectly. 
For example, AvrPita, an effector protein from Magnaporthe grisea, interacts directly with the 
NLR Pi-ta from rice in yeast and in vitro (Jia et al., 2000). The indirect detection of an 
effector by a NLR is more common. The ‘guard hypothesis’ describes the ability of a NLR to 
detect a biochemical modification of a host protein by a pathogen effector (Dangl and Jones, 
2001; Van der Biezen and Jones, 1998). In doing so, the host takes advantage of the 
pathogen’s virulence strategy to initiate a successful immune response. The guard 
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hypothesis implies that multiple effectors modify the same host target in different ways and 
that the host target can guarded by multiple NLRs (Jones and Dangl, 2006). This is because 
ETI is a driving force of the host-pathogen arms race and is consistent with the finding that 
pathogen effectors converge on a subset of host proteins (Mukhtar et al., 2011). A classic 
example of the guard hypothesis that fulfills these tenets is the targeting of the Arabidopsis 
protein RIN4 (RPM1-Interacting Protein 4) by multiple P. syringae T3Es. AvrRpt2-mediated 
cleavage of RIN4 and phosphorylation of RIN4 in the presence of AvrRpm1 and AvrB, 
trigger the activation of NLRs RPS2 and RPM1, respectively (Axtell and Staskawicz, 2003; 
Mackey et al., 2003; Mackey et al., 2002). 
The molecular mechanisms that govern NLR activation and signaling are not fully 
understood and there are few generalizable themes describing NLR activation (Bonardi et 
al., 2012; Bonardi and Dangl, 2012; Eitas and Dangl, 2010). This is likely due to their rapid 
evolution in the arms race and the ability to detect virulence effectors from a diverse range 
of plant pathogens. Plant NLRs are similar to CATERPILLER/NOD/LRR proteins and 
STAND ATPases (Leipe et al., 2004; Ting and Davis, 2005). STAND ATPases are 
molecular switches that cycle between an ADP-bound off state and an ATP-bound on state. 
Similarly, NLRs contain a critical catalytic sequence, called the P loop, in their nucleotide-
binding domain. The P loop domain is not required for the function of all NLRs. For example, 
NLR activation, basal resistance to virulent pathogens, and salicylic acid accumulation 
mediated by the ADR1 family of NLRs does not require P loop function (Bonardi et al., 
2011). Proper activation of NLRs requires a conformational change to release the 
intramolecular interactions. Additionally, homotypic or heterotypic interactions or the 
formation of large complexes may be required for NLR activation (Bonardi and Dangl, 2012).   
ETI is a more rapid and higher amplitude form of PTI. The PTI outputs described 
above such as ion influx, ROS burst, MAPK cascade signaling, and reprogramming of gene 
expression also occur during ETI. However, a rapid and localized cell death at the site of 
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infection called the hypersensitivity response or HR often occurs once ETI is triggered 
(Jones and Dangl, 2006). Although the exact mechanism by which ETI restricts pathogen 
growth is unknown, mutation of R genes or in genes encoding chaperones required for NLR 
stability results in an increase in susceptibility to pathogens.  
The phytohormone ethylene plays multiple roles in the plant defense response. 
There are three main hormones in plants that regulate the plant defense response 
against abiotic and biotic stresses: salicylic acid (SA), jasmonic acid (JA), and ethylene. The 
simplest model of how these hormones function states that ethylene and JA mediate 
resistance to necrotrophs and herbivorous insects, while SA mediates resistance to 
biotrophs (Robert-Seilaniantz et al., 2007). Although there are a few exceptions, the 
ethylene and JA pathways are synergistic to each other and antagonistic to SA (Ecker and 
Davis, 1987; Penninckx et al., 1998; Schenk et al., 2000). There is cross-talk between these 
pathways to allow the plant to fine tune its defense response against the multiple invaders it 
may encounter.  
In recent years, there have been numerous examples of plant pathogens that hijack 
specific hormone-regulated signaling pathways, supporting the hypothesis that 
phytohormones are important components of the plant defense response. A well-studied 
example is coronatine, a toxin from P. syringae pv. tomato DC3000 (hereafter Pto DC3000). 
Coronatine triggers a hyper-induction of ethylene- and JA-mediated responses. This results 
in the suppression of SA-dependent responses that are responsible for resistance against 
biotrophs like P. syringae, leading to enhanced bacterial growth (Cui et al., 2005; Laurie-
Berry et al., 2006; Schroeder and Hilbi, 2008; Zhao et al., 2003). The P. syringae T3E HopI1 
suppresses SA accumulation (Jelenska et al., 2007). Additionally, AvrPtoB stimulates ABA 
(abscisic acid) biosynthesis and ABA responses that also antagonize SA biosynthesis and 
SA-mediated defenses (de Torres-Zabala et al., 2007). AvrRpt2 alters the auxin physiology 
to promote host susceptibility (Chen et al., 2007). XopD, a T3E from Xanthomonas 
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campestris pv. vesicatoria, (Xcv) was recently found to target a tomato ethylene response 
factor (ERF) called SIERF4. SIERF4 mutants display reduced ethylene levels and an 
increase in susceptibility to Xcv (Kim et al., 2013), supporting the hypothesis that ethylene is 
involved in plant defense.  
Ethylene is a gaseous plant hormone that is required for normal plant development 
processes such as seed germination, leaf senescence, and leaf and petal abscission 
(Kieber, 1997). As mentioned above, ethylene biosynthesis is induced during the plant 
defense response. This occurs after recognition of PAMPs and the induction of the MAPK 
signaling cascade. Phosphorylation stabilizes ACS (aminocyclopropane carboxylate 
synthase) proteins and thus increases the biosynthesis of ethylene (Liu and Zhang, 2004).  
There is a growing body of work focused on elucidating the role of ethylene in 
defense against pathogens. Ethylene up-regulates the expression of pathogenesis-related 
(PR) proteins and increases the accumulation of hydroxyproline-rich, cell-wall strengthening 
proteins (Ecker and Davis, 1987; Penninckx et al., 1998). Ethylene also increases SA-
induced expression of PR-1. This suggests that in addition to functioning synergistically with 
JA, ethylene can also support SA-dependent defense responses (Lawton et al., 1994). 
Furthermore, ethylene directly up-regulates the expression of FLS2. FLS2 transcription is 
directly controlled by the binding of ERFs EIN3/EIL1/EIL2 to the FLS2 promoter and in 
ethylene insensitive mutants (ein2), both FLS2 expression and FLS2 protein accumulation 
are suppressed. As a result, ein2 plants are more susceptible to weakened strains of P. 
syringae (Boutrot et al., 2010; Mersmann et al., 2010).  
However, there is also data supporting the idea that pathogens up-regulate ethylene 
as a part of their virulence strategy. For example, P. syringae T3Es AvrPto and AvrPtoB 
promote increases in the biosynthesis of ethylene to promote disease symptoms in tomato 
(Cohn and Martin, 2005). ET-responsive transcription factors EIN3 and EIL1 repress PAMP-
induced genes, including the SA biosynthesis gene SID2 and the suppression of SA 
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promotes susceptibility to P. syringae (Chen et al., 2009). Furthermore, ethylene perception 
is also necessary for manifestation of disease symptoms, following Pto DC3000 infection in 
Arabidopsis (Bent et al., 1992). In conclusion, the role of ethylene in plant defense signaling 
pathways is complex and needs more attention. Further experimentation is required for 
complete understanding of how all phytohormones regulate defense pathways and how 
pathogens promote disease by disrupting hormone homeostasis.  
Successful pathogens suppress PTI /ETI activation and signaling. 
Well-adapted pathogens have evolved methods to breach the multiple lines of plant 
defense described above. Pathogens employ effectors to block components of PTI, ETI, or 
both. Fungi and oomycetes encode hundreds of effectors as part of their virulence 
strategies. However, little is known about their function and mechanisms by which they 
thwart plant immune systems. For that reason, in this section, we will mainly focus on T3Es 
from bacterial phytopathogens, mostly from Pseudomonas syringae. Bacterial pathogen 
strains can each inject approximately 20 to 30 virulence effectors into the host cell during 
infections, and strains across one widespread species, Pseudomonas syringae deploy 
approximately 60 protein families, many of which have highly variable members (Baltrus et 
al., 2011) (Figure 1.1; Table 1.1).  
The type III secretion system and its effectors are the main virulence determinants of 
Pseudomonas syringae. 
Before detailing how T3Es target various defense machinery in the plant cell to 
suppress immune system input signaling and outputs responses, it is important to digress to 
first introduce the type III secretion system. This will be followed by a detailed discussion of 
T3E functions, largely in the context of the plant pathogen P. syringae.  
The type III secretion system  
In order to cause disease, pathogenic bacteria interact with their host in a variety of 
ways. These include using various secretion systems, toxins, and adhesions to exploit or 
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disrupt normal host processes and defense responses. One widespread and critical 
bacterial virulence mechanism  is the type III secretion system (T3SS), which consists of a 
multi-ring base located in the bacterial inner and outer membranes and a protruding needle-
like appendage. This needle-like pilus is called the Hrp pilus in phytopathogenic bacteria. 
The Hrp pilus is used to deliver T3Es into the host cell to cause disease. The T3SS is 
conserved across a broad range of Gram-negative pathogens including animal pathogens 
such as Salmonella, Yersinia pestis, and Escherichia coli and phytopathogens 
Pseudomonas syringae, Ralstonia solanacearum and various Xanthomonas species 
(Chatterjee et al., 2013; Deslandes and Rivas, 2012; Raymond et al., 2013).  
Arabidopsis-P. syringae model system 
P. syringae causes disease in agronomically important crops such as tomatoes, 
tobacco, and beans. P. syringae also infects Arabidopsis thaliana, a genetically tractable 
model plant system (Whalen et al., 1991). Since P. syringae was also considered to be 
genetically tractable, this established a new plant-pathogen system for studying molecular 
mechanisms utilized by pathogens to causes disease progression and the subsequent host 
defense responses.  
P. syringae can survive in a surprisingly large number of environmental reservoirs 
such as rivers, snow, and clouds (Morris et al., 2007; Morris et al., 2010; Morris et al., 2008). 
Additionally, P. syringae can infect a wide range of plant hosts. The life cycle of P. syringae 
begins with epiphytic growth on the surfaces of the aerial parts of plants, such as leaves and 
flowers. Some strains of P. syringae, such as P. syringae pv. syringae B728A, can multiply 
to high titers as an epiphyte, while others, such as Pto DC3000, must enter the apoplast to 
multiply significantly (Feil et al., 2005). Given the proper environmental conditions, such as 
during high humidity or heavy rain, P. syringae can enter the apoplastic region inside of 
leaves via stomatal openings. In the apoplast, transcription of the T3SS genes, which are 
encoded by the tightly linked hrp (hypersensitivity response and pathogenicity) and hrc 
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(hypersensitivity response and conserved) genes, is up-regulated. Although the specific in 
planta signal that is responsible for up-regulating the hrp and hrc genes is unknown, Huynh 
et al., demonstrated that fructose, sucrose, and mannitol upregulate AvrB transcription in 
defined media (Huynh et al., 1989). Although P. syringae remains extracellular, the T3SS 
translocates T3Es into the host cell to suppress components of PTI and ETI and contribute 
to pathogenicity (Grant et al., 2006). P. syringae type III secretion system mutants are 
nonpathogenic; therefore the type III secretion system and its effectors are required for the 
pathogenicity of P. syringae (Lindgren et al., 1986). Furthermore, Lindgren et al., suggested 
that these same effectors are responsible for HR triggered in non-host plants (Lindgren et 
al., 1986).   
Bacterial genomics, next generation sequencing, and definition of T3E families 
The effort to identify T3E families in all strains of P. syringae is ongoing and has 
involved many approaches over the years. Scoring robust effector loss-of-function 
phenotypes using transposon mutagenesis screens is difficult because, due to functional 
redundancy of sequence un-related T3Es, there is often only a weak, or even undetectable, 
contribution of any single effector to virulence. Therefore, identification of T3Es has relied 
heavily on bioinformatics-based methods. Research on the molecular mechanisms of P. 
syringae T3Es has focused on the three ‘gold standard’ P. syringae strains that were 
genome sequenced first; Pto DC3000, P. syringae pv. syringae B728A, and P. syringae pv. 
phaseolicola 1448A (Buell et al., 2003; Feil et al., 2005; Joardar et al., 2005).  
Type III effectors have several conserved features that allow for pattern-based 
genome searches. Studies were performed that searched the promoters of type III effectors 
for the hrp-box, a cis-acting element transcriptionally up-regulated by the alternative sigma 
factor HrpL. Chang et al., published the results of a differential fluorescence induction 
screen that identified type III effectors in Pto  DC3000 and P. syringae pv. phaseolicola 
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1448A (Chang et al., 2005). This was followed by validation of the translocation of the 
candidate effector proteins (Chang et al., 2005).  
Next generation DNA sequencing has made it possible to quickly generate data on 
multiple, diverse P. syringae genomes. Using a combination of Illumina and 454 platforms, 
Baltrus et al., generated draft genome sequences for 14 previously unsequenced, 
phylogenetically diverse strains of P. syringae (Baltrus et al., 2011). The search for type III 
effectors among these genomes led to the identification of eight new type III effectors 
families, resulting in a total of approximately 60 T3E families in this diverse collection of P. 
syringae strains that expands the five distinct phylogroups (Baltrus et al., 2011).  
Effectors that target PTI 
Multiple effectors target RLKs at the plasma membrane and downstream 
components of PTI signaling pathways. AvrPto and AvrPtoB share no primary or structural 
homology, but they are redundant P. syringae T3Es that suppress the function of RLKs. 
AvrPtoB has an N-terminal kinase domain that is sufficient to suppress flg22-induced PTI 
(Gohre et al., 2008). The C-terminus of AvrPtoB is an E3 ubiquitin ligase domain that can 
ubiquitinate and degrade RLKs FLS2 and CERK1 (Gimenez-Ibanez et al., 2009; Gohre et 
al., 2008). AvrPto can bind and inhibit the activity of FLS2 and EFR (Xiang et al., 2008). 
Although, it has been reported that AvrPto and AvrPtoB can inhibit BAK1 function, there is 
conflicting evidence for this interaction (Shan et al., 2008; Xiang et al., 2011). AvrPphB 
cleaves kinases, such as BIK1, that function downstream of PAMP recognition and integrate 
signals from multiple PRRs to block PTI responses (Zhang et al., 2010). Interestingly, 
AvrPphB cleavage of PBS1 triggers RPS5-mediated ETI in Arabidopsis inbreds that carry 
the functional RPS5 NLR receptor gene (Ade et al., 2007; Shao et al., 2003). AvrAC, a T3E 
from Xanthomonas campestris pv. campestris also inhibits PTI by targeting BIK1 and RIPK 
(Feng et al., 2012). HopF2 and HopAI1 suppress PTI by inhibiting MAPK cascades. HopF2 
ADP-ribosylates MKK5 and inhibits its kinase activity (Wang et al., 2010). HopAI1 uses 
32 
phosphothreonine lysase activity to inhibit the function of MPK3 and MPK6 (Zhang et al., 
2007). Similar to HopF2, disruption of PTI by targeting MAPK cascades triggers activation of 
a NLR and ETI (Zhang et al., 2012).  
Using effectors as probes of plant cell biology and plant defense has led to the 
identification of components of the plant immune system that extend beyond PRRs and 
NLRs. HopM1 targets vesicle trafficking by inhibiting the function of an Arabidopsis ARF-
GEF protein MIN7. HopM1 degradation of MIN7 is proteasome-dependent (Nomura et al., 
2006). Interestingly, when ETI is triggered by AvrRpt2, AvrPphB, and HopA1, HopM1-
mediated destabilization of MIN7 is inhibited (Nomura et al., 2011). This demonstrates a 
novel situation in which ETI contributes to plant defense by preventing bacterial suppression 
of a key component of PTI (Nomura et al., 2011). HopU1 is a P. syringae type III effector 
mono-ADP-ribosyltransferase that targets Arabidopsis glycine-rich RNA binding proteins 
(GR-RBPs) GRP7 and GRP8 (Fu et al., 2007). HopU1 negatively affects the ability of GRP7 
to bind RNA (Jeong et al., 2011). Specifically, HopU1 blocks the interaction between GRP7 
and FLS2 and EFR transcripts (Nicaise et al., 2013), leading to a reduction in FLS2 
accumulation after infection with a virulent P. syringae strain expressing HopU1 (Nicaise et 
al., 2013). This is consistent with HopU1 inhibiting PAMP responses triggered by flg22, such 
as callose deposition (Fu et al., 2007). T3Es HopZ1a and HopZ1b have also been 
implicated in PTI suppression. HopZ1a and HopZ1b degrade the soybean protein GmHID1 
(2-hydroxyisoflavanone dehydratase), a protein involved in the biosynthesis of antimicrobial 
phytoalexins (Zhou et al., 2011). Soybean plants with GmHID1 silenced are more 
susceptible to  infection (Zhou et al., 2011). HopZ1a also interacts with and acetylates 
tubulin to inhibit formation of stable cytoskeletons (Lee et al., 2012). HopZ1a expression 
blocks callose formation (Lee et al., 2012). Additionally, HopI1 localizes to the chloroplast 
where it inhibits Hsp70 function, which leads to a decrease in SA and suppression of PTI 
(Jelenska et al., 2010; Jelenska et al., 2007). Overexpression of HopN1 leads to a decrease 
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in PAMP-induced ROS burst and callose deposition (Rodriguez-Herva et al., 2012). Finally, 
HopG1 also inhibits callose and ROS burst, although the molecular mechanism is currently 
unknown (Block et al., 2010).  
Effectors that block ETI 
The first evidence of type III effectors blocking HR came from studies in the 1990s in 
which Xanthomonas campestris pv. campestris hrp mutants induced a programmed cell 
death in the vascular system of crucifers (Jackson et al., 1999). This suggested that there 
are type III effectors in the hrp regulon that are blocking this HR-like response. More recent 
studies have identified P. syringae type III effectors that are involved in suppressing ETI. For 
example, Jackson et al. demonstrated that VirPphA, AvrPphC, and AvrPphF from P. 
syringae pv. phaseolicola were able to inhibit NLR activation (Jackson et al., 1999). AvrPtoB 
suppresses ETI-associated programmed cell death in tomato plants via ubiquitin ligase 
activity in its C-terminus (Abramovitch et al., 2003). HopF2 targets RIN4 and blocks ETI 
(Wilton et al., 2010). AvrAC can also block ETI (Feng et al., 2012). Furthermore, Jamir et al., 
showed that effectors could inhibit cell death triggered in yeast, suggesting those effectors 
target programmed cell death pathways conserved in eukaryotes (Jamir et al., 2004).  
Subcellular localizations and enzymatic functions of P. syringae type III effectors  
As described above, T3Es can inhibit PTI and ETI and thus contribute to virulence. 
Given the diversity of targets noted above for particular T3Es, it is not surprising to learn that 
they function in various subcellular locations. Thus, determining the role of any T3E in 
bacterial virulence requires multiple approaches and gathering pertinent forms of data, such 
as the subcellular localization of the effector, the enzymatic function, and a potential host 
target.  
Determining the subcellular localization of a T3E in a plant cell can help determine 
which host pathways or host defense mechanisms are targeted by the effectors. AvrRpm1 
and AvrB were the first T3Es found to be targeted to the plasma membrane via the 
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eukaryotic-specific posttranslational modification of fatty acid acylation at the N-terminus 
(Nimchuk et al., 2000). At the plasma membrane that AvrRpm1 and AvrB trigger the 
phosphorylation of RIN4, leading to the elicitation of RPM1-mediated ETI. Myristoylation 
sites of AvrRpm1 and AvrB are required to trigger ETI (Nimchuk et al., 2000). Since then 
multiple type III effectors such have been shown to localize to the plasma membrane via 
acylation and their functions are dependent on their proper targeting (Dowen et al., 2009; 
Lewis et al., 2008; Robert-Seilaniantz et al., 2006; Shan et al., 2000).  
The chloroplasts, mitochondria, and nucleus are all organelles targeted by T3Es. 
HopI1 is targeted to the chloroplasts via a noncanonical targeting sequence (Jelenska et al., 
2007). HopI1 alters thylakoid structure, suppresses SA accumulation and SA-related 
defenses and interacts with Hsp70 (Jelenska et al., 2010; Jelenska et al., 2007). HopN1 
also is targeted to the chloroplast, where it degrades a photosystem II protein, PsbQ 
(Rodriguez-Herva et al., 2012). HopG1 is targeted to the mitochondria and although its 
specific protein target it currently unknown, HopG1 causes a reduction in PAMP-induced 
callose deposition and ROS burst (Block et al., 2010). Although there are no published 
examples of P. syringae T3Es being targeted directly to the nucleus, the AvrBs3 family of 
T3Es from Xanthomonas spp. are targeted to the nucleus, where they act as transcriptional 
activators to directly regulate host gene expression (Boch and Bonas, 2010).   
Along with specific localizations, many T3Es have specific enzymatic activities used 
to disrupt host processes and suppress PTI/ETI. Unfortunately, these diverse biochemical 
functions have only recently started to be deciphered. Several type III effectors have been 
shown to possess cysteine protease activity. AvrRpt2 cleaves RIN4, which activates the 
RIN4-associated NB-LRR receptor, RPS2 (Kim et al., 2005). AvrPphB is a cysteine protease 
that cleaves PBS1, which activates RPS5 (Shao et al., 2003). HopN1 is also a cysteine 
protease that cleaves PsbQ (Lopez-Solanilla et al., 2004). There are other identified 
enzymatic functions for T3Es. HopAO1 is a protein tyrosine phosphatase (Espinosa et al., 
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2003). HopU1 is an ADP ribosyltransferase (Fu et al., 2007). AvrAC is a uridylyl transferase 
from Xanthomonas campestris pv. campestris (Feng et al., 2012). HopX1 is predicted to be 
a transglutaminase (Nimchuk et al., 2007). While the transglutaminase function has not 
been shown, the putative catalytic residues are required for HopX1-triggered ETI in beans 
(Nimchuk et al., 2007).  
Assigning enzymatic functions to T3Es is challenging. T3Es have relatively low 
conservation at the primary amino acid sequence level to proteins of known biochemical 
function. This suggests that convergent evolution into conserved folds to modify host 
signaling pathways. Solving crystal structures of T3Es is way to help determine a conserved 
structure associated with a function and/or specific residues required for function (Boutemy 
et al., 2011; Jeong et al., 2011; Lee et al., 2004; Singer et al., 2004). In lieu of an actual 
crystal structure, generating tertiary structure predictions can also provide some information 
about the function of a T3E. AvrRpm1 is predicted to have a fold similar to the catalytic 
domain of poly-ADP-ribosyl polymerase and the central domains of HopQ1 is predicted to 
have homology to nucleoside hydrolase enzymes (Cherkis et al., 2012; Li et al., 2013). 
Additionally, SseI from Salmonella is predicted to have deamidase function based on 
homology to the bacterial deamidase PMT. However, despite many efforts, SseI has not 
been shown to have deamidation activity (Bhaskaran and Stebbins, 2012). Deamidation is 
the irreversible conversion of glutamine and asparagines to glutamic acid and aspartic acid, 
respectively. Since deamidation is emerging as a posttranslational modification utilized by 
multiple bacterial toxins to modify host signaling pathways, we will explore bacterial 
deamidases further in Chapter 2 (Washington et al., 2013).  
Although the enzymatic activities of multiple T3E proteins have been discovered, the 
link between enzymatic activity, the function of each effector’s host cellular target protein, 
and the mechanism of suppression of both ETI and PTI often remain unclear. Unraveling 
how T3Es use enzymatic activity to disrupt the function of host proteins will reveal details of 
36 
the molecular mechanisms by which these host proteins function normally. For some highly 
conserved host proteins this may have implications beyond pathology that expand into the 
realms of host cell signaling pathways and cell biology.    
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Figure 1.1. P. syringae type III effectors target multiple host cellular components. 
Adapted from Xin and He, 2013. Bacterial PAMPs, such as flagellin, trigger PTI. P. syringae 
injects type III effector proteins into the plant cell, via the type III secretion system, to block 
components of PTI and ETI. AvrPto and AvrPtoB inhibit the activity of PRRs at the plasma 
membrane through inhibition of PRR kinase activity or degradation, respectively. AvrPphB 
cleaves BIK1, PBS1, and PBS1-like proteins (PBLs). HopF2 ADP-ribosylates MKK5 and 
inhibits its activity. HopF2 may also inhibit PTI at the site of the plasma membrane by 
blocking BIK1 phosphorylation. HopAI1 also targets the MAPK signaling cascade by using 
phosphothreonine lyase activity to inhibit the function of MPK3 and MPK6. HopU1 is a 
mono-ADP-ribosyltransferase that targets glycine-rich RNA-binding proteins (GR-RBPs). 
HopU1 prevents GRP7 from interacting with FLS2 and EFR transcripts, leading to a 
reduction in FLS2 transcript and protein accumulation. HopM1 targets vesicle trafficking by 
inhibiting the function of the ARF-GEF protein MIN7.  HopZ1a has been reported to have 
multiple roles. HopZ1a degrades HID1, a protein involved in biosynthesis of antimicrobial 
phytoalexins in soybean. HopZ1a also acetylates tubulin. Recently, HopZ1a has been 
reported to target a pseudokinase, ZED1, which triggers ZAR1-mediated recognition in 
Arabidopsis. Multiple effectors target RIN4. AvrRpt2 cleaves RIN4, triggering RPS2-
mediated ETI. HopF2 blocks ETI triggered by AvrRpt2 by interacting with RIN4.  
Phosphorylation of RIN4 in the presence of AvrRpm1 and AvrB is mediated by RIPK. AvrPto 
and AvrPtoB can degrade RIN4. Finally, AvrB targets RIN4 in complex with 
MPK4/RAR1/Hsp90 to alter jasmonate signaling. HopI1is targeted to the chloroplast, where 
it alters thylakoid structure, suppresses SA acculumation, and SA-related defenses. HopN1 
is also targeted to the chloroplast. HopN1 degrades photosystem II protein, PsbQ. Although 
HopG1 localizes to the mitochondria, its direct target and function remain unknown. 
Table 1.1. P. syringae type III effectors: defense suppression, localization, activities and targets 
Effector Host target(s) Biochemical Activity Subcellular Key References 
AvrB RIN4/RAR1/MPK4 ? Plasma membrane (Cui et al., 2010; Mackey et al., 2002;Nimchuk et al., 2000) 
AvrPphB PBS1/BIK1/PBLs Cysteine protease Plasma membrane (Ade et al., 2007; Dowen et al., 2009; Shaoet al., 2003; Zhang et al., 2010) 
AvrPto Pto/Fen/EFR/FLS2/ 
BAK1? ? Plasma membrane 
(Shan et al., 2000; Xiang et al., 2011; Xiang
et al., 2008) 
AvrPtoB Pto/Fen/BAK1/FLS2/RLKs/BAK1? E3 ubiquitin ligase ? 
(Gimenez-Ibanez et al., 2009; Gohre et al., 
2008; Shan et al., 2000; Xiang et al., 2011; 
Xiang et al., 2008) 
AvrRpm1 RIN4 Poly-ADP-
ib lt f ?
Plasma membrane (Cherkis et al., 2012; Nimchuk et al., 2000) 
AvrRpt2 RIN4 Cysteine protease ? (Axtell et al., 2003; Axtell et al., 2001; Axtell and Staskawicz, 2003) 
HopAI1 MPK3/MPK6 Phosphothreonine lyase ? (Zhang et al., 2007) 
HopAO1 ? Tyrosine phosphatase ? (Espinosa et al., 2003) 
HopI1 Hsp70 J domain Chloroplast (Espinosa et al., 2003; Jelenska et al., 2010; Jelenska et al., 2007) 
HopF2 RIN4/MKK5 Mono-ADP-ribosyltransferase Plasma membrane 
(Robert-Seilaniantz et al., 2006; Wang et
al., 2010; Wilton et al., 2010) 
HopG1 ? ? Mitochondria (Block et al., 2010) 
HopM1 AtMIN7 ? Vesicles (Nomura et al., 2006; Nomura et al., 2011) 
HopN1 PsbQ Cysteine protease Chloroplast (Rodriguez-Herva et al., 2012) 
HopU1 GRP7, GRP8 Mono-ADP-
ib lt f
Nucleo-cytoplasmic (Fu et al., 2007; Jeong et al., 2011) 
HopX1 ? Transglutaminase? ? (Nimchuk et al., 2007) 
HopZ1a/b GmHID1; ZED1 Acetyltransferase?/cysteine protease? 
Plasma membrane  
Microtubules (a) 
(Lee et al., 2012; Lewis et al., 2008; Lewis 
et al., 2013; Zhou et al., 2011) 
HopZ2 ? Acetyltransferase?/cysteine protease? Plasma membrane 
(Lee et al., 2012; Lewis et al., 2008; Zhou et
al., 2011) 
HopZ3 ? Acetyltransferase?/cysteine protease? ? 
(Lee et al., 2012; Lewis et al., 2008; Zhou et 
al., 2011) 
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 Chapter 2 
Bacterial virulence factors modulate eukaryotic host cell signaling systems via 
deamidation 
 
Preface 
The following chapter was published in September 2013 in Microbiology and 
Molecular Biology Reviews under the title “What a difference a Dalton makes: Bacterial 
virulence factors modulate eukaryotic host cell signaling systems via deamidation” (2013, 
77, 527-539). I wrote this manuscript while planning and completing experiments for the 
work described in Chapter 3. I received direction and edits from our collaborator, Mark 
Banfield, from the John Innes Centre in Norwich, UK and my thesis advisor, Jeff Dangl.  
Abstract 
Pathogenic bacteria commonly deploy enzymes to promote virulence. These 
enzymes can modulate the function of host cell targets. While the actions of some enzymes 
can be very obvious (e.g. digesting plant cell walls), others have more subtle activities. 
Depending on the lifestyle of the bacteria these subtle modifications can be crucially 
important for pathogenesis. In particular, if bacteria rely on a living host, subtle mechanisms 
to alter host cellular function are likely to dominate. Several bacterial virulence factors have 
evolved to use enzymatic deamidation as a subtle post-translational mechanism to modify 
the function of host protein targets. Deamidation is the irreversible conversion of amino 
acids glutamine and asparagine to glutamic acid and aspartic acid, respectively. 
Interestingly, all currently characterized bacterial deamidases affect the function of the target 
protein by modifying a single glutamine residue in the sequence. Deamidation of target host 
proteins can disrupt host signaling and downstream processes by either activating or 
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inactivating the target. Despite the subtlety of this modification, it has been shown to cause 
dramatic, context-dependent, effects on host cells. Several crystal structures of bacterial 
deamidases have been solved. All are members of the papain-like superfamily and display a 
cysteine-based catalytic triad. However, these proteins form distinct structural subfamilies 
and feature combinations of modular domains of various functions. Based on the diversity of 
pathogens that use deamidation as a mechanism to promote virulence, and the recent 
identification of multiple deamidases, it is clear that this enzymatic activity is emerging as an 
important and widespread feature in bacterial pathogenesis. 
Introduction 
Many bacterial pathogens use diverse suites of virulence factors to contribute to 
pathogenicity. These virulence factors include toxins and type III effectors, proteins injected 
into host cells via specialized type III secretion systems. Effectors often modify eukaryotic 
host target proteins with posttranslational modifications that alter normal cellular function. 
Commonly described posttranslational modifications utilized by effectors include 
ubiquitination, acetylation, and AMPylation (Cui and Shao, 2011; Ribet and Cossart, 2010; 
Yarbrough and Orth, 2009). Recently, enzymatic deamidation has emerged as a common 
posttranslational modification utilized by a broad range of bacterial pathogens of both plants 
and animals to alter the function of host proteins. Deamidation is the substitution of an 
amide group with a carboxylate group (Figure 2.1). Therefore, it converts glutamines and 
asparagines to glutamic acid and aspartic acid, respectively. This irreversible amino acid 
conversion results in an increase of approximately 1 Dalton in the mass of the target protein, 
an increase in the negative charge of the target protein, and the release of ammonia. 
Nonspecific deamidation can occur spontaneously as proteins age and are degraded 
(Robinson and Rudd, 1974). In contrast, specific enzymatic deamidation can regulate 
normal cellular functions, such as chemotaxis and protein turnover in prokaryotes, or to 
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disrupt eukaryotic host cell function during infection (Chao et al., 2006; Striebel et al., 2009). 
Here, we focus on deamidases that contribute to bacterial virulence.  
The topic of this review is the six currently known families of bacterial virulence 
factors that use deamidation to modulate host functions during infection (Table 2.1). 
Cytotoxic Necrotizing Factors, CNFs, are a family of deamidases from E. coli (CNF1, 2, and 
3) and Yersinia pseudotuberculosis (CNFY). The CNFs target a glutamine residue (either 
Gln63 or Gln61) in the switch II domain of GTPase proteins that is critical for function (Flatau 
et al., 1997; Schmidt et al., 1997). Deamidation of this glutamine leads to constitutive 
activation of the target GTPases, resulting in cytoskeletal rearrangements. Reorganization 
of the actin cytoskeleton is one mechanism used by invasive bacteria to promote entry into 
host cells (Doye et al., 2002; Galan and Zhou, 2000). BLF1 is a toxin from Burkholderia 
pseudomallei that is lethal to mice and tissue culture cells (Cruz-Migoni et al., 2011). BLF1 
inhibits host protein synthesis via deamidation of eIF4A (Cruz-Migoni et al., 2011). VopC is a 
type III effector from Vibrio parahaemolyticus that deamidates and constitutively activates 
small GTPases (Zhang et al., 2012). Pasteurella multocida toxin (PMT) is the major 
virulence factor of Pasteurella multocida, the causal agent of a variety of mammalian and 
avian diseases. PMT constitutively activates various G proteins including Gαq/11, Gαi, and 
Gα12/13 via deamidation of a glutamine that is also in the switch II region (Orth et al., 2009). 
Cell cycle inhibiting factors, Cifs, are type III effectors and cyclomodulins from multiple 
bacterial species. Cifs inhibit ubiquitination pathways by deamidating glutamine 40 of 
ubiquitin and the ubiquitin-like protein, NEDD8 (Cui et al., 2010).  OspI is a type III effector 
protein from Shigella flexneri that dampens host immune responses by deamidating UBC13 
and disrupting the TRAF6-mediated signaling pathway (Sanada et al., 2012). We review the 
details of each of these six families, specifically with respect to their three-dimensional 
structures and the impact that deamidation has on the function of their host target proteins. 
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We conclude that deamidation, as a non-reversible modification, is likely an all or nothing 
virulence switch to alter diverse cellular functions across diverse pathosystems. 
Cytotoxic Necrotizing Factor Toxins 
Cytotoxic Necrotizing Factor toxins deamidate Rho GTPases. 
Cytotoxic Necrotizing Factor, CNF1, from E. coli was the first bacterial deamidase 
identified (Flatau et al., 1997; Schmidt et al., 1997). CNF1 is expressed in uropathogenic 
strains of E. coli (Caprioli A, 1983). Following the discovery of CNF1, a number of 
homologues were identified in different strains of E. coli. For example, CNF2 is produced by 
enteropathogenic E. coli strains isolated from cows and sheep (Oswald et al., 1989). The 
amino acid sequence of CNF2 is 85% identical to CNF1. CNF3 was isolated from 
necrotoxigenic E. coli that infects sheep and goats (Orden et al., 2007). CNF3 shares 70% 
amino acid identity with CNF1. Interestingly, CNFs are not restricted to E. coli. Yersinia 
pseudotuberculosis produces CNFY, which is 61% identical to CNF1 (Lockman et al., 2002). 
Further, dermonecrotizing Toxin, DNT, from Bordetella is a virulence factor that also shares 
sequence homology with CNF1. However, DNT behaves most efficiently as a 
transglutaminase in vitro, active in the presence of polyamines (Masuda et al., 2000; 
Schmidt et al., 2001). Therefore, we will not include a detailed discussion of DNT here.  
Schmidt et al. and Flatau et al. demonstrated that CNF1 converts Gln63 of the critical 
RhoA GTPase switch II region to glutamic acid via enzymatic deamidation (Flatau et al., 
1997; Schmidt et al., 1997). Importantly, neither Gln29 nor Gln52, the other two glutamine 
residues in RhoA, were modified by CNF1 (Flatau et al., 1997; Schmidt et al., 1997). 
Deamidation of Gln63 triggers constitutive activation of RhoA, functionally mimicking the 
GTP-bound state. Furthermore, the RhoA Gln63Glu variant, that mimics the product of the 
deamidation reaction, phenocopies the CNF1-treated RhoA on microinjection into Vero cells 
(Flatau et al., 1997; Schmidt et al., 1997).  
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RhoA is not the only target of CNFs. CNF deamidases possess different GTPase 
substrate specificities. CNF1 can deamidate Rac and Cdc42 in vitro and Cdc42 in intact 
HeLa cells (Lerm et al., 1999; Schmidt et al., 1997). CNF2 can modify RhoA and Rac when 
co-expressed in E. coli (Sugai et al., 1999). CNF3 can deamidate RhoA, Rac, and Cdc42 in 
intact HeLa cells treated with recombinant toxin (Stoll et al., 2009). Although RhoA, Rac, 
and Cdc42 serve as substrates for CNFY deamidation in vitro, only RhoA could be 
deamidated by CNFY in intact cells (Hoffmann et al., 2004).   
Rho GTPases are molecular switches that cycle between an  inactive, GDP-bound 
state and an active, GTP bound state (Heasman and Ridley, 2008). The active state initiates 
a variety of downstream responses, including reorganization of the actin cytoskeleton. Rho 
GTPases that are unable to hydrolyze GTP are maintained in a constitutively active state.  
Activation of different members of the Rho GTPases family leads to specific effects on the 
cytoskeleton. RhoA activation leads to actin reorganization into stress fibers, Rac activation 
causes membrane ruffling, and Cdc42 activation causes the formation of filopodia (Nobes 
and Hall, 1995; Ridley and Hall, 1992; Ridley et al., 1992).  Treatment with CNF1 induces 
stress fiber formation, microspikes, membrane ruffles, and multinucleation in intact cells 
(Flatau et al., 1997; Lerm et al., 1999; Schmidt et al., 1997). CNF3 and CNFY also trigger 
strong formation of actin stress fibers in intact cells (Hoffmann et al., 2004; Stoll et al., 2009). 
Surprisingly, there is no evidence of CNF3-triggered membrane ruffling or filopodia 
formation. It has been demonstrated that CNF1 is required for the invasion of uropathogenic 
E.coli into uroepithelial cell monolayers (Doye et al., 2002). This is consistent with other 
bacterial pathogens, such as Salmonella, that attack the host cytoskeletal to facilitate 
bacterial entry (Galan and Zhou, 2000).  
The C-terminus of CNF1 forms a single compact catalytic domain. 
CNFs are modular proteins. The N-terminal domains of these toxins are required for 
binding and entry into host cells via receptor-mediated endocytosis (Contamin et al., 2000; 
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Lemichez et al., 1997). The structure of the catalytic C-terminus of CNF1 (residues 720-
1014) revealed a three-layered α/β/β sandwich, consisting of two mixed 5-stranded β-sheets 
that are flanked by two α-helices (Figure 2.2A) (Buetow et al., 2001). The structure of CNF1 
identified a novel overall protein fold that contained an arrangement of residues in the active 
site reminiscent of the papain-like superfamily of enzymes that include the transglutaminase 
blood coagulation factor XIII and GMP synthetase (Buetow and Ghosh, 2003). More 
recently, it was determined that CNF1 is also structurally similar to Thermotoga maritima 
deamidase protein, CheD, and a bacterial protein of unknown function, YfiH (Chao et al., 
2006). Papain-like superfamily enzymes typically contain a catalytic triad consisting of 
histidine, cysteine, and asparagine/aspartic acid. The cysteine and histidine form a thiolate-
imidazolium pair that is critical for activating the cysteine nucleophile, with the 
asparagine/aspartic acid thought to be involved in orienting the histidine. CNF deamidases 
contain the invariant cysteine and histidine residues (Schmidt et al., 1998). Interestingly, in 
CNF1, valine is the third member of the catalytic triad and this residue is involved in 
orienting the histidine through a main chain carbonyl hydrogen bond (Buetow et al., 2001). 
Structure-based mutagenesis of conserved residues in the catalytic pocket identified 
Asn835 and Ser864 that are also required for CNF1 activity (Figure 2.2A) (Buetow and 
Ghosh, 2003). Further, deletion of five individual loop regions surrounding the CNF1 
catalytic pocket revealed that loops 8 and 9 are required for deamidation of RhoA (Buetow 
and Ghosh, 2003). Most likely Asn835 and Ser864 have indirect roles in catalysis and loops 
8 and 9 are important for substrate recognition. 
A peptide derived from RhoA residues 59-69 could be deamidated by CNF1, thus 
defining the minimal region of RhoA required for CNF1 deamidation (Flatau et al., 2000). 
Mutations outside of these key residues did not interfere with the ability of CNF1 to 
deamidate RhoA (Flatau et al., 2000). This suggests that CNF1 interacts with a narrow 
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surface of RhoA, and likely other GTPase substrates, and does not require a significant 
binding surface for substrate recognition.  
Burkholderia Lethal Factor 1 inhibits activity of translation factor eIF4A. 
Burkholderia Lethal Factor 1, formerly known as BPSL1549, is a potent toxin from 
Burkholderia pseudomallei. Melioidosis is a disease caused by infection with Burkholderia 
pseudomallei, a pathogen endemic in areas in Southeast Asia and northern Australia 
(Wiersinga et al., 2006). It is associated with severe septicemia and can remain dormant in 
the host for decades. The molecular basis for the pathogenicity of B. pseudomallei is poorly 
understood. 
BLF1 interacts with the human translation factor eIF4A in a human cell lysates (Cruz-
Migoni et al., 2011), suggesting that BLF1 might inhibit translation. This interaction was 
confirmed by co-immunoprecipitation. BLF1 reduces endogenous host cell protein synthesis 
and triggers increased stress granule formation, which is associated with translational 
blocks. In order to determine the outcome of the BLF1/elF4A interaction, FLAG-tagged 
eIF4A was purified from human cells expressing BLF1. Subsequent mass spectrometric 
analysis of eIF4A revealed deamidation of Gln339 to Glu. To determine how deamidation of 
this residue altered eIF4A activity, the Gln339Glu variant was generated. Although this 
variant was capable of binding both RNA and ATP, and maintained wild-type levels of 
ATPase activity, helicase activity was reduced by 47% (Cruz-Migoni et al., 2011).  
The crystal structure of BLF1 revealed an α/β fold comprising a sandwich of two 
mixed β-sheets surrounded by loops and α-helices (Figure 2.2B) (Cruz-Migoni et al., 2011). 
The β-sheet core of the catalytic pocket is structurally similar to that of the deamidase 
domain of CNF1, with an rmsd of 3.9 Angstroms over 170 residues (Cruz-Migoni et al., 
2011). Interestingly, these deamidase domains share only 9% amino acid identity. BLF1 
lacks the receptor binding and translocation domains of CNF1, an expected evolutionary 
innovation, since the intra-cellular lifestyle of B. pseudomallei renders these domains 
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unnecessary. However, the invariant catalytic residues found in CNF1, cysteine and 
histidine, are conserved in the catalytic pocket. The third residue of the catalytic triad in 
BLF1 is a threonine. BLF1 deamidation of eIF4A and efficient inhibition of protein translation 
is dependent on the catalytic cysteine as mutation of this residue to a serine renders BLF1 
essentially non-functional (Cruz-Migoni et al., 2011). 
Vibrio parahaemolyticus type III effector VopC deamidates small GTPases. 
A recent addition to the CNF family of deamidases is VopC from Vibrio 
parahaemolyticus. V. parahaemolyticus is an enteric pathogen that contains two type III 
secretion systems, TTSS1 and TTSS2 (Broberg et al., 2011); TTSS2 is encoded within a 
pathogenicity island. The V. parahaemolyticus TTSS2 is necessary and sufficient for 
invasion of and replication in both HeLa cells and CaCo2 cells. Among the type III effectors 
encoded in the T3SS2 pathogenicity island is VopC, which shares 20% amino acid identity 
to the catalytic domain of CNF from E. coli. As VopC is a type III effector protein it does not 
share the same mechanism for host cell delivery as CNF1. As a result, VopC and CNF1 
have different N-terminal domains. 
Both the catalytic cysteine and histidine residues of CNF1 are conserved in VopC 
(Cys220 and His235). Although a VopC structure has yet to be determined, homology 
modeling suggests that the carbonyl oxygen of Leu187 completes the papain-like catalytic 
triad. VopC deamidates and constitutively activates small GTPases, Rac and Cdc42, to 
facilitate host cell invasion (Zhang et al., 2012). VopC is not able to activate RhoA. However, 
as noted above, differences in substrate specificity are common among CNF homologs. 
VopC activates Rac by deamidating Gln61 on the critical switch II domain. V. 
parahaemolyticus invasion of nonphagocytic HeLa cells is dependent on catalytically active 
VopC (Zhang et al., 2012). 
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Pasteurella multocida toxin 
PMT is a multidomain toxin, with catalytic activity located at the C-terminus. 
Pasteurella multocida toxin, PMT, is a monomeric, 146 kDa enzyme. P. multocida 
causes severe diseases in animals and humans. It is associated with atrophic rhinitis in pigs 
and dermatonecrosis and respiratory diseases, also known as snuffles, in cattle and rabbits 
(Felix et al., 1992; Mushin and Schoenbaum, 1980). In humans, P. multocida can cause 
dermonecrosis from bite wounds and bacteremia (Garcia, 1997).  
PMT is a multidomain toxin. The N-terminal region of PMT has sequence homology 
with the N-termini of CNFs, suggesting that this region is also used for binding to the host 
cell surface. In fact, the first 506 N-terminal residues of PMT are sufficient to bind to cells 
and to compete with full-length toxin in this assay (Pullinger et al., 2001).  
The C-terminal region of PMT contains the catalytic center of the enzyme and is 
sufficient for PMT-mediated toxicity when delivered into cells by electroporation (Pullinger et 
al., 2001). The crystal structure of the C-terminal region of PMT reveals a multi-domain 
Trojan horse-like structure with the feet, head, and body consisting of different domains (C1, 
C2 and C3) that possess different functions (Figure 2.3A). The C1 domain, or the feet, 
consists of seven α-helices. The N-terminal α-helices of the C1 domain are structurally 
similar to the N-terminal domain of Clostridium difficile toxin B (Kamitani et al., 2010). In 
toxin B, these helices target the protein to the plasma membrane. Similarly, the first four α-
helices of C1 are required to target the catalytic domain of PMT to the plasma membrane 
(Kamitani et al., 2010; Kitadokoro et al., 2007). Deletion of the C1 domain causes a 
reduction, but not a complete loss, of PMT function, suggesting that localization to the 
plasma membrane is necessary for full PMT-induced toxicity (Kamitani et al., 2010). 
The function of the C2 domain, the body of the Trojan horse, is currently unknown. It 
is the largest section of the PMT C-terminal region and consists of two subdomains. Each 
subdomain contains typical α/β folds. Searches using the DALI server revealed possible 
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structural homology between the second subdomain and phosphate binding enzymes 
(Kitadokoro et al., 2007). Therefore, the C2 domain may be enzymatic or may be involved in 
binding target proteins in the host cell.  
The C3 domain is the catalytic deamidase domain of PMT. Residues Cys1165 and 
His1205 (which form the thiolate-imidazolium pair) and His1223 are required for PMT 
function (Orth et al., 2003; Ward et al., 1998). Comparison with the structures of other 
members of the papain-like superfamily reveals Asp1220 of PMT is the third residue of the 
catalytic triad. Mutation of any of these residues resulted in a complete loss of PMT function 
(Kitadokoro et al., 2007). Interestingly, the function of the catalytic cysteine requires the 
reduction of a disulfide bond with Cys1159 (Figure 2.3B) (Kitadokoro et al., 2007). 
Reduction of the disulfide bond between Cys1159 and Cys1165 causes a rotation of the 
Cys1165 side chain towards the catalytic triad (Figure 2.3C). Therefore, the disulfide bond 
has to be reduced for complete deamidase activity. Additionally, a Gln1225 in the catalytic 
cleft was shown to be required for deamidase activity. It is postulated that this glutamine 
forms an oxyanion hole to stabilize the tetrahedral intermediate, similar to the role of Gln19 
in papain (Kitadokoro et al., 2007). 
PMT deamidation of heterotrimeric G protein families affects several downstream signaling 
events. 
Unlike bacterial toxins that have high specificity for their host targets, such as the 
CNFs, PMT mediates its virulence effect through activation of multiple heterotrimeric G-
protein families. This leads to a plethora of changes in host signaling that lead to 
dysregulation of normal host cell homeostasis. A variety of cell systems and assays have 
been used to establish that the pleiotropic effects of PMT in target cells are due to the ability 
of PMT to activate multiple α subunits of diverse heterotrimeric G proteins (Hennig et al., 
2008; Lacerda et al., 1996; Orth et al., 2007; Orth et al., 2008; Orth et al., 2005; Preuss et 
al., 2009; Staddon et al., 1990; Takasaki et al., 2004; Thomas et al., 2001; Wilson et al., 
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1997; Zywietz et al., 2001).  Heterotrimeric G proteins consist of four major families; Gαs, 
Gαi, Gαq/11, and Gα12/13. When PMT and Gαi proteins were co-expressed in E. coli, PMT 
modifies Gαi via deamidation (Orth et al., 2009). PMT converts the conserved Gln205 in the 
switch II region of Gαi to glutamic acid. PMT-mediated activation of Gαi proteins leads to the 
inhibition of adenylyl cyclase and reduction of cAMP accumulation (Figure 2.4) (Orth et al., 
2008).  
PMT activation of Gαq/11 proteins results in the stimulation of phospholipase Cβ 
(PLCβ) (Figure 2.4). PLCβ catalyzes the hydrolysis of phostidylinositol-4,5-bisphosphate to 
inositol-1,4,5-triphosphate and diacylglycerol. It was originally postulated that PMT was 
capable of activating Gαq (Orth et al., 2004; Zywietz et al., 2001). However, more recent in 
vitro expression assays coupled with a mass spectrometry output demonstrated that PMT is 
also able to deamidate Gα11 (Orth et al., 2012). PMT-induced Gα11 activation of PLCβ is 
weaker than the Gαq activation of PLCβ (Kamitani et al., 2011). Therefore, although PMT 
can deamidate and activate both Gαq and Gα11 in vitro, the relative contributions of these 
activities in vivo may differ. Regardless, activation of the Gαq/11 sub-family via PMT results in 
an increased release of second messengers inositol-1,4,5-triphosphate and diacylglycerol, 
and a consequent increase in calcium mobilization. This leads to multiple calcium-mediated 
responses such as activation of protein kinase C and secretion of chloride ions (Hennig et 
al., 2008; Staddon et al., 1990; Wilson et al., 1997). PMT also stimulates the JAK/STAT 
pathway in a Gαq- dependent manner (Orth et al., 2007).  
PMT also activates the small GTPase RhoA, resulting in reorganization of the actin 
cytoskeleton and formation of actin stress fibers (Lacerda et al., 1996; Thomas et al., 2001). 
PMT induces RhoA indirectly through activation of multiple heterotrimeric Gα protein families 
(Figure 2.4). PMT-induced RhoA activation can occur through Gαq (Wilson et al., 1997; 
Zywietz et al., 2001) and Gα12/13 (Orth et al., 2005). A novel cyclic peptide that specifically 
inhibits Gαq partially blocked PMT-induced RhoA activation (Orth et al., 2005; Takasaki et 
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al., 2004). Additionally, PMT-induced RhoA activation was inhibited in Gα12/13-deficient 
HEK293m3 cells (Orth et al., 2005). However, it was not clear whether PMT functioned 
through Gα12, Gα13, or both. Recently, mass spectrometric analysis revealed that PMT can 
deamidate both Gα12 and Gα13 (Orth et al., 2012).  
Finally, because Gα activation leads to the release of Gβγ from the heterotrimeric 
complex, PMT also stimulates increased signaling through Gβγ-specific effectors such as 
phosphoinositide-3-kinase (Figure 2.4) (Preuss et al., 2009). 
Cycle Inhibiting Factors 
Members of the cycle inhibiting factor (Cif) family of deamidases are found in many bacterial 
pathogens. 
Enteropathogenic (EPEC) and enterohemorrhagic (EHEC) E. coli are causal agents 
of intestinal diarrhea (Croxen and Finlay, 2010; Kaper et al., 2004). EPEC is the cause of 
potentially fatal diarrhea in infants in developing countries. In contrast, highly infectious 
EHEC outbreaks occur most often in developed countries, most notably North America, 
Japan, and Europe. Although the diseases caused by these two E. coli pathovars differ, they 
both cause the formation of attaching and effacing (A/E) lesions (Croxen and Finlay, 2010). 
The genes responsible for attaching and effacing lesions, the type III secretion system and 
type III effectors, are encoded in the 35 kb pathogenicity island called the locus of 
enterocyte effacement (LEE) (McDaniel et al., 1995). However, several effectors are non-
LEE encoded (Nle) (Dean and Kenny, 2009). Cif was the first Nle effector identified in EPEC 
and EHEC (Marches et al., 2003). 
Cif homologs are encoded in multiple bacterial pathogen genomes and are all 
associated with horizontally transferred genetic elements (Jubelin et al., 2009; Marches et 
al., 2003). Cif homologues from Burkholderia pseudomallei, Yersinia pseudotuberculosis, 
Photorhabdus luminescens, and Photorhabdus asymbiotica have been named CHBP, 
CHYP, CHPL, and CHPA, respectively. Interestingly, these proteins have low primary amino 
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acid identity compared to Cif from E. coli: 56% for CHYP, 26% for CHBP, 23% for CHPL and 
26% for CHPA (Jubelin et al., 2009; Yao et al., 2009). 
Deamidation of NEDD8 by Cif leads to disruption of the ubiquitin-proteasome system. 
CifEc was shown to interact with NEDD8 in a yeast-2-hybrid system and this 
interaction was verified by in vitro pull-down and co-expression assays (Cui et al., 2010; 
Jubelin et al., 2010; Morikawa et al., 2010). Cif proteins modify NEDD8 and ubiquitin via 
deamidation (Cui et al., 2010). Ubiquitin and ubiquitin-like (UBL) proteins such as NEDD8 
control many cellular processes by targeting various proteins for degradation through the 
ubiquitin-proteasome system. Ligation of ubiquitin and UBLs, such as NEDD8, to substrate 
proteins requires a series of three enzymes; an E1-activating enzyme, an E2-conjugating 
enzyme, and an E3 ligase. Cullin-RING ligase (CRLs) are a large superfamily of E3 ubiquitin 
ligases (Wei et al., 2008). The core CRL complex consists of cullin proteins, which are the 
scaffold proteins of CRLs and are modified by NEDD8, and a small RING protein. 
In eukaryotic cells, cullins are continuously neddylated and deneddylated. The 
conjugation and removal of NEDD8 is an important cycling mechanism that regulates CRL 
activity. The COP9 signalosome (CSN), a conserved multiprotein complex with protease 
activity, is responsible for cullin deneddylation (Wei et al., 2008). When cullins are 
neddylated they are maintained in an active, open conformation that allows substrate 
proteins to interact with the Rbx protein at the cullin C-terminus (Duda et al., 2008). This 
flexible protein conformation and interaction leads to the ubiquitination and subsequent 
degradation of target proteins, some of which include important cell cycle regulators (Figure 
2.5A).  
Cifs target residue Gln40 in NEDD8 and ubiquitin with exquisite selectivity (neither 
Gln39 nor Gln41 of NEDD8 is a target for deamidation) (Cui et al., 2010; Yao et al., 2012). 
To date, recombinant CifEc, CifBp and CifYp have all been shown to deamidate Gln40 of 
NEDD8 in vitro (Cui et al., 2010; Yao et al., 2012). Ectopic expression of the Gln40Glu 
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NEDD8 variant in HeLa cells phenocopies either the ectopic expression of Cifs or the effects 
of Cif during bacterial infection demonstrating this activity is responsible for the Cif-mediated 
cytopathic phenotype.  
The deamidation of NEDD8 by Cif results in reduction in the rate of cullin 
deneddylation (Boh et al., 2011; Jubelin et al., 2010; Morikawa et al., 2010). The Gln40Glu 
mutation in NEDD8 is sufficient to decrease the deneddylation rate by the CSN in the 
absence of Cif (Boh et al., 2011). Gln40 is located close to the cullin-NEDD8 conjugation 
site. Deamidation of Gln40 in NEDD8 may prevent CSN-mediated deneddylation of CRLs 
through interference with the global NEDD8-induced conformational change of cullins (which 
may be necessary for CSN recognition (Figure 2.5B) (Boh et al., 2011). In contrast to 
previous studies, it was shown in yeast that CSN can remove deamidated NEDD8 from 
CRLs more efficiently than wild-type NEDD8 (Toro et al., 2013). This causes an increase in 
deneddylated CRLs. Additionally, it is appropriate to mention that deamidation of NEDD8 
and subsequent effects on CRL activity have not been reconstituted in vitro. Therefore, the 
exact effect of Cif-mediated deamidation of NEDD8 remains unclear. 
Cif causes cytopathic phenotypes such as rearrangement of the host cytoskeleton 
and the formation of actin stress fibers. However, the hallmark of Cif infection is the 
inhibition of cell cycle progression. These multiple cytopathic phenotypes can be directly 
attributed to disruption of the ubiquitin-protease system. Depending on the stage of the cells 
during infection, Cifs can arrest the cell cycle at either the G1/S transition or the G2/M 
transition (Marches et al., 2003; Taieb et al., 2006). G1/S and G2/M transitions require 
complexes that consist of a cyclin and a cyclin-dependent kinase (CDK). Inhibiting CRL 
activity prevents ubiquitination and degradation of cell cycle regulators such as p21 and p27, 
resulting in inactivation of cyclin-dependent kinases and cell cycle arrest (Marches et al., 
2003; Samba-Louaka et al., 2008; Taieb et al., 2006). This triggers an increase in the 
inactive and phosphorylated CDKs, leading to cell cycle arrest (Marches et al., 2003).  
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Cifs also inhibit the degradation of a variety of other CRL substrates such as pIκB, 
Cdt1, β-catenin, and RhoA (Marches et al., 2003). Therefore, inhibition of CRL activity can 
account for the multiple phenotypes observed during infection with bacterial species 
expressing Cifs.  
Multiple structures reveal that Cif proteins are members of the papain-like superfamily. 
The crystal structures of CifEc, CHBP, CHYP, and CHPL have been solved (Figure 
2.6). Although the primary amino acid similarity among the homologs is low, the structures 
are highly conserved (Crow et al., 2009; Hsu et al., 2008). The disordered N-termini provide 
type III secretion signals and are either not included in expressed proteins or are not 
observed in the crystal structures. To date, the only crystal structure of CifEc includes 
truncation of the first 100 amino acids (Hsu et al., 2008). The overall fold of Cifs comprises a 
head-and-tail domain organization (Figure 2.6A). The tail region, also known as the helical 
extension domain, is encoded in the N-terminus of the protein. The head domain, also 
known as the globular core, is formed by the C-terminus of the protein. The head domain 
consists of an anti-parallel β-sheet surrounded by α-helices. This globular domain displays 
overall structural homology to the papain-like superfamily. Similar to the other deamidases 
covered in this review, the active sites of all Cifs contain an invariant Cys-His thiolate-
imidazolium pair. The third residue of the catalytic triad in Cifs is a glutamine (Figure 2.6B). 
Each of these catalytic residues are required for Cif-induced cytopathic effects, deamidation 
of NEDD8 and ubiquitin, and the resulting increase in stability of cell cycle regulators, p21 
and p27 (Cui et al., 2010; Hsu et al., 2008; Jubelin et al., 2009; Yao et al., 2009).  
An interesting feature observed in the structures of Cifs is the so-called occluding 
loop. This loop was first identified in CifEc and is conserved across the Cif family (Crow et al., 
2009; Hsu et al., 2008). The occluding loop partially blocks access to the catalytic site 
(substrate binding cleft of papain) and was hypothesized to be important in defining 
specificity for Cif substrates (Figure 2.6B; see below).  
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Cif deamidases were the first to be co-crystallized with their substrates. 
The crystal structures of CHYP, CHPL, and CHBP have been determined in complex 
with NEDD8 (Crow et al., 2012; Yao et al., 2012). Additionally, the co-crystal structure of 
CHBP and ubiquitin has also been determined (Yao et al., 2012). The structure of these 
complexes reveals an extensive binding interface between Cif proteins and their 
ubiquitin/NEDD8 substrates (Figure 2.7A), which involves both the head and the tail 
domains of Cifs. Multiple alanine mutations in CHBP in the regions that interface with either 
the N-terminal β-hairpin or the residues adjacent to Gln40 in ubiquitin or NEDD8 were 
sufficient to abolish deamidation and Cif-induced cell cycle arrest (Yao et al., 2012). 
Furthermore, alanine mutations in the corresponding residues in ubiquitin and NEDD8 
disrupted both the interaction and deamidation (Yao et al., 2012). Interestingly, all individual 
alanine mutations in CHYP (that were tested) were not sufficient to disrupt NEDD8 complex 
formation. Only mutations that introduced steric clashes (based on the complex structure) 
prevented binding (Yao et al., 2012). 
There is very little change in the structure of Cifs when bound to their substrates, 
compared to the uncomplexed states (Crow et al., 2012; Crow et al., 2009; Yao et al., 2012). 
However, a significant re-orientation of the flexible C-terminal tail of NEDD8 and ubiquitin is 
observed on binding by Cifs. Interestingly, it is the occluding loop in Cifs that appears 
responsible for forcing this re-orientation during substrate binding. Displacement of the 
flexible C-terminal tail is likely important for substrate recognition and orienting Gln40 in the 
Cif catalytic pocket (Crow et al., 2012; Yao et al., 2012). Consistent with this, deletion of the 
C-terminal domain of either ubiquitin or NEDD8 diminished deamidation by Cifs (Crow et al., 
2009). Therefore, multiple areas within the extensive interface between Cif deamidases and 
their substrates are important for activity.  
CHBP has a preference for NEDD8 as a substrate (Cui et al., 2010), and CHYP 
deamidation of NEDD8 is ten-fold more efficient than deamidation of ubiquitin (Crow et al., 
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2012). Molecular-dynamics studies revealed that this efficiency difference may be due to 
decreased flexibility of NEDD8 in complex with Cif, compared to ubiquitin (Yao et al., 2012). 
Residue Glu31 of NEDD8 interacts electrostatically with several residues in CHBP. The 
residue at the same position in ubiquitin is glutamine, which is not capable of electrostatic 
interactions. To determine whether this residue contributes to the difference in movement 
and deamidation efficiency, NEDD8 Glu31Gln and the ubiquitin Gln31Glu variants were 
generated. NEDD8 Glu31Gln exhibited increased molecular dynamic motion in simulations 
and deamidation efficiency in in vitro assays was comparable to that observed for wild-type 
ubiquitin. Conversely, ubiquitin Gln31Glu exhibited decreased molecular-dynamic motion, 
bound more tightly to CHBP, and was deamidated at a level similar to wild-type NEDD8 
(Yao et al., 2012). Thus, the Gln31 substrate residue may determine the difference in 
substrate deamidation efficiency by Cifs.  
The data from the Cif/NEDD8 complexed structures also suggests a molecular 
mechanism of enzymatic deamidation by Cifs (Figure 2.7B,C). All solved structures of 
currently known enzymatic deamidases contain conserved papain-like catalytic residues and 
α/β folds similar to those in the papain-like superfamily. As a result, the molecular 
mechanism of deamidation is likely to be similar to the protease and transglutaminase 
reactions catalyzed by other superfamily members. During these reactions, the catalytic 
histidine residue deprotonates the cysteine sulfhydryl group to increase its ability to act as a 
nucleophile. Then, this nucleophile attacks the amide substrate, resulting in an acyl-enzyme 
intermediate that is resolved by hydrolysis. The catalytic histidine’s imidazole ring is often 
coordinated by a hydrogen bond with a third residue and this is ensures optimal orientation 
of the thiolate-imidazolium pair (Figure 2.7B,C) (Crow et al., 2012).  
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OspI inhibits host immune responses by deamidating an E2-conjugating enzyme. 
Deamidation of Ubc13 by OspI inhibits host inflammatory responses. 
Shigella species are routinely found in patients in developing countries that suffer 
from severe diarrhea (Schroeder and Hilbi, 2008). The severe symptoms associated with 
Shigella infections are due to the invasion and destruction of the colonic and rectal 
epithelium and a severe inflammatory reaction (Schroeder and Hilbi, 2008).  
S. flexneri infections trigger changes to the host cell membrane that initiate the DAG 
(diacylglycerol)-CBM complex-NF-κB signaling pathway. S. flexneri invades the host cell via 
macropinocytosis. It is then able to escape from the phagosome and into the cytoplasm 
through an unknown mechanism (Dupont et al., 2009). The escape leads to the 
accumulation of host membrane components near the site of infection and subsequent host 
signaling events that lead to inflammation. This likely occurs through the activation of 
phospholipases that hydrolyze plasma membrane phospholipids, such as DAG, which then 
activate protein kinases (Rawlings et al., 2006). Subsequently, protein kinases activate the 
complex of caspase-recruitment domain (CARD), B-cell lymphoma 10 (BCL-10), and 
mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1(MALT1). This complex 
is also referred to as the CBM complex. The CBM complex interacts with and activates 
tumor-necrosis factor receptor-associated factor 6 (TRAF6). TRAF6 is an E3 ubiquitin ligase 
that interacts with the Ubc13, an E2 ubiquitin-conjugating enzyme, to form lysine 63 (Lys63)-
linked polyubiquitin chains (Takeuchi and Akira, 2010). The presence of unconjugated 
Lys63 polyubiquitin chains activates the TGF-β-activated kinase 1 (TAK1), TAK1-binding 
protein 1 (TAB1), and TAK1-binding protein 2 (TAB2) complex. This leads to IκBα 
phosphorylation and degradation. This allows NF-κB to translocate into the nucleus, where it 
activates the expression of proinflammatory cytokine genes (Takeuchi and Akira, 2010).  
S. flexneri encodes a type III effector, OspI, which modulates this host response by 
deamidating Ubc13. Incubation of OspI with TRAF6, ubiquitin conjugating E2 enzymes 
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(UBC13 and UEV1A), and ubiquitin revealed that OspI causes a shift in the mobility of 
Ubc13 in SDS-PAGE gels. Mass spectrometry analysis revealed that Ubc13 is deamidated 
at residue Gln100 in the presence of OspI (Sanada et al., 2012). The deamidation of Ubc13 
Gln100 blocks its ubiquitin-conjugating activity, thereby inhibiting the TRAF6-DAG-CBM 
complex and subsequent NF-κB signaling. This is made evident by the increase in 
phosphorylation of the NF-κB inhibitor, IκBα, and consequent NF-κB translocation to the 
nucleus in HeLa cells infected with S. flexneri ∆ospI (Sanada et al., 2012). Consistent with 
this result, NF-κB translocation to the nucleus is inhibited in the presence of OspI (Sanada 
et al., 2012).  
OspI forms a papain-like catalytic pocket that rearranges upon binding Ubc13. 
The crystal structure of OspI reveals an α/β fold with 4 β-strands, seven α-helices, 
and one 310 helix (Figure 2.8A) (Sanada et al., 2012). OspI also shares structural homology 
with the papain-like superfamily, as noted above for PMT and the Cif family of deamidases. 
It is most closely related to the Pseudomonas syringae cysteine protease effector AvrPphB 
(Shao et al., 2002; Zhu et al., 2004).  
Superimposition of the catalytic domain of AvrPphB with the OspI crystal structure 
revealed that the catalytic triad in OspI comprises Cys62, His145, and Asp160 (Sanada et 
al., 2012). OspI inhibition of the DAG-CBM-NF-κB pathway is dependent on the catalytic 
residues as mutation of any of these residues leads to the loss of OspI activity (Sanada et 
al., 2012).  
Recently, the crystal structure of the OspI(Cys62Ala)/Ubc13 complex has been 
solved (Figure 2.8B,C) (Fu et al., 2013). This structure revealed that an extensive binding 
surface between OspI and Ubc13 that covers 11% of the exposed surface of OspI (Fu et al., 
2013). A negatively-charged region and hydrophobic pocket of OspI bind α-helix 1 and the 
L1 and L2 loops of Ubc13, respectively. Analysis of point mutations in these regions 
revealed that both interfaces are required for deamidation of Ubc13 (Fu et al., 2013). In 
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contrast to Cifs, significant structural rearrangements occur in the catalytic pocket of OspI 
upon substrate binding (Fu et al., 2013). In uncomplexed OspI, the catalytic pocket is 
blocked by Asn61 (Figure 2.8A). When OspI binds Ubc13, Asn61 rotates approximately 180 
degrees. This leads to formation of a hydrogen bond with Asn54 and repositioning of Ala62. 
The movement of these residues opens the pocket allowing insertion of Gln100 from Ubc13 
into the catalytic site. Superposition of the catalytic pockets of AvrPphB and Ubc13-bound 
OspI reveals an overlap of OspI Ala62 (Cys62 in the wild-type protein) and the catalytic 
cysteine of AvrPphB (Fu et al., 2013). This suggests that the remodeled OspI catalytic 
pocket (when bound to Ubc13) contains the proper orientation for catalytic activity. 
Additionally, Phe95 and His96 of OspI re-orient to form a hydrophobic pocket that interacts 
with Ubc13 loops L1 and L2 (Fu et al., 2013). 
The OspI/Ubc13 complexed structure confirms that the molecular mechanism of 
OspI is similar to that of papain-like enzymes and that suggested for Cif/NEDD8 
deamidation (Figure 2.7C) (Fu et al., 2013; Storer and Menard, 1994; Zhu et al., 2004). It is 
interesting to note that the catalytic cysteine is capable of forming disulfide bonds with 
Cys65 (Figure 2.8C) (Sanada et al., 2012). Although, it has not been demonstrated that this 
disulfide bond affects the function and positioning of the catalytic cysteine, it is possible that 
it maintains the deamidase in a non-catalytic state in non-reducing conditions, as has been 
demonstrated for PMT (Figure 2.3B,C) (Kitadokoro et al., 2007).  
Conclusions 
Recently, it has been discovered that deamidation is a common mode of action used 
by several bacterial virulence factors to modify the function of host proteins. Deamidation, as 
an irreversible modification of host proteins, offers many advantages to invading pathogens. 
Unlike phosphorylation, host systems lack the ability to reverse the effects of deamidation. 
This makes deamidases particularly potent virulence factors. Characterized deamidases 
have been shown to modify specific residues on host proteins that are key to the host 
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protein’s function. Additionally, there is high specificity in the proteins that are targeted by 
deamidases, as can be seen in the ability of CNF1 to deamidate some by not all Rho 
GTPases. Although the deamidation modification is subtle and specific, the downstream 
impacts on host cell function are extensive. This is most evident in the case of cycle 
inhibiting factors, which inhibit the ubiquitin-protease system leading to both cell cycle arrest 
and cytoskeletal rearrangements. In fact, it is apparent that bacterial deamidase virulence 
factors have evolved to target key modulators of critical cell signaling systems in hosts. 
However, our understanding of the role of deamidases in bacterial virulence is still in 
its infancy. Further elucidation of the molecular mechanisms and the interactions between 
deamidases and their substrates is important.   To date, the use of enzymatic deamidation 
as a generic “house-keeping” mechanism for modifying protein function has only been 
documented in prokaryotes. Do eukaryotes also use this activity to modulate protein 
activity? Or is enzymatic deamidation in eukaryotic cells an innovation of bacterial pathogen 
mediated via translocated proteins? Future work would be greatly aided by new methods for 
easier identification of deamidation. Current methods require knowledge of the specific 
substrate of each deamidase in order for activity to be assayed. This differs from enzymes 
such as cysteine proteases, for which cleavage of generic substrates can be easily 
measured. Additionally, the presence of nonspecific deamidation in protein samples can 
make the identification of enzymatic deamidation difficult. Another important future direction 
is to define the molecular mechanisms by which deamidation specifically impacts the 
function of host cell targets. At present, our knowledge is restricted to observing the 
phenotypic outcomes of deamidation on particular targets during diverse steps in the 
lifestyles of diverse pathogens. It would be valuable to understand how deamidation alters 
function at the level of the modified protein. For example, G proteins are commonly targets 
of at least some of the deamidases discussed here. But is the phenotypic outcome of these 
events always merely an irreversible loss of catalytic function or could the deamidated G 
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protein now act as a dominant negative on its normal cellular partners, amplifying the impact 
of the deamidation event to multiple output pathways, as noted above for PMT. Such 
understanding will be important, for example, in exploration of genome editing to target 
glutamine to glutamate mutations.    
Regardless of the challenges of these studies, it is clear that tackling the molecular 
mechanisms of deamidation, as has been done for other posttranslational modifications 
used by bacterial pathogens, is essential for our understanding of bacterial pathogenesis 
and, in fact, for the normal host cell biology of their targets.   
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Figures 
 
Figure 2.1. A schematic representation of enzymatic deamidation in proteins. 
Deamidases act on specific residues in the target protein. For all currently studied bacterial 
virulence factors, the targets of deamidation are glutamine side chains, which are converted 
to glutamic acids. However, it is also possible for the amide of the side chains of 
asparagines to be converted to aspartic acid. Deamidation results in an increase in the 
negative charge of the target protein, an increase of approximately 1 Dalton in the mass of 
the target protein, and the release of ammonia. Each of these outputs can be measured 
experimentally to characterize the activity of deamidases.  
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Figure 2.2. The catalytic domains of diverse deamidases. A) Catalytic domain of CNF1 
from E. coli (PDB 1HQ0) is shown with invariant catalytic residues Cys866 and His881 
shown in purple. The main chain carbonyl of Val833 (also in purple) is involved in 
coordinating the imidazole ring of His881. In pink are conserved residues important for 
CNF1 function, whilst loops 8 and 9 (likely important for substrate recognition) are shown in 
yellow. B) BLF1 (PDB 3TU8) is a 23 kDa toxin and deamidase that forms a compact 
catalytic domain structurally related to CNF1 from E. coli and other papain-like superfamily 
enzymes. The residues that comprise the catalytic triad (Cys94, His106, and Thr88) are 
shown in purple. α-helices are in blue, β-sheets in green, and loops in grey. All structure 
figures were prepared with PyMol. 
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Figure 2.3. Crystal structure of the C-terminal region of Pasteurella multocida toxin. 
A) The crystal structure of the C-terminal region of PMT has been solved (residues 575-
1285, PDB 2EBF). The catalytic region consists of several domains. The helical C1 domain 
(purple), are the feet of the Trojan horse, and contain membrane-targeting properties. The 
C2 “body” domain contains 2 α/β subdomains (shown in green and yellow) of unknown 
function. The domain responsible for the deamidase activity of PMT is the C3 “head” C-
terminal domain (blue). B) The crystal structure of PMT catalytic domain reveals a disulfide 
bond between the catalytic cysteine, Cys1165 and Cys1159 in the binding pocket. 
Reduction of this disulfide bond is required for the interaction of the catalytic triad and 
catalytic activity. His1205 and Asp1220 form the other residues of the triad.  
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Figure 2.4. PMT deamidates and activates heterotrimeric Gα proteins. The activation of 
diverse G protein-couple receptor signal transduction pathways by PMT leads to several 
phenotypes that are disruptive to the host. PMT activates Gαi, Gαq/11, and Gα12/13, but not 
Gαs. PMT also triggers the release of Gβγ from the heterotrimeric complex, which leads to 
activation of the phosphoinositide-3-kinase (PI3K) pathway. 
 
  
76 
 
Figure 2.5. Model of Cif inactivation of CRL activity and ubiquitination. A) In uninfected 
cells, the COP9 signalosome (CSN) deneddylates CRLs. NEDD8 (yellow) conjugation and 
removal represent an important mechanism by with CRL activity is regulated. When CRLs 
are neddylated with wild-type NEDD8 (green), they are maintained in an open conformation. 
This allows substrates (blue) to bind the CRLs, become polyubiquitinated, and then 
degraded. B) In cells infected with bacteria that express Cif, deamidation of NEDD8 (yellow) 
may prevent CRL (green) from forming an open conformation.  This prevents CRLs from 
associating with the substrate-binding module that allows downstream ubiquitination and 
degradation of substrate proteins (blue) to occur. This may lead to a reduction in the rate of 
deneddylation and a decrease in unmodified CRLs (grey).  
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Figure 2.6. Crystal structures of cell cycle-inhibiting factors. A) Crystal structures of Cif 
deamidases from E. coli (PDB 3EFY), B. pseudomallei (PDB 3GQM), P. luminescens (PDB 
3GQJ), and Y. pseudotuberculosis (PDB 4F8C) are shown. In blue are the α-helices of the 
core globular domain. In teal are the α-helices of the tail helical extension domain. The 
antiparallel β-sheet is green and the loops are colored in grey, except for the occluding loop, 
which is colored in black. The conserved catalytic residues histidine, cysteine, and 
glutamine are in purple. B) Amino acids in the catalytic domain of CHBP are shown as sticks 
in purple. 
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Figure 2.7. Crystal structure of the CifYp deamidase/NEDD8 complex. A) The CHYP (α-
helices in blue, β-sheets in green, and loops in grey) and NEDD8 (red) complex consists of 
an extensive interaction surface (PDB 4FBJ). The catalytic Cys117 position is modeled 
based on the CHYP(Cys117Ala)/NEDD8 complex to demonstrate the proposed molecular 
mechanism of deamidation. B) An up-close view of the catalytic domain of CHYP shows the 
deamidation target, Gln40 of NEDD8, is positioned near the Cif catalytic residues (shown in 
purple). C) The proposed molecular mechanism of deamidation involves deprotonation of 
the cysteine by the imidazolium group of histidine (step 1) followed by a nucleophilic attack 
by the thiol group of the catalytic cysteine on the δ-carbon of glutamine (step 2). 
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Figure 2.8. Crystal structures of unbound OspI and the OspI/Ubc13 complex. A) OspI 
(α-helices in blue, β-sheets in green, and loops in grey (PDB 3B21) forms a compact 
catalytic domain structurally similar to papain-like superfamily enzymes. The residues in the 
catalytic triad (Cys62, His145, and Asp160) are shown in purple. The catalytic pocket is 
blocked by Asn61 in free OspI. B) The OspI(Cys62Ala)/Ubc13 (red) complex includes an 
extensive interaction surface involving Ubc13 α-helix 1 and loops L1 and L2 (PDB 4IP3). C) 
An up-close view of the OspI(Cys62Ala)/Ubc13 complex showing Gln100 of Ubc13 
positioned adjacent to the OspI catalytic center (purple, OspI residue 62 has been modeled 
as a cysteine to demonstrate the nucleophilic attack (yellow dashes) by the thiol group of 
Cys62 on Gln100 in Ubc13).  
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Table 2.1. Bacterial virulence factors that use deamidation to modify host proteins. 
Protein Species Target Effects Key References 
Cytotoxic 
Necrotizing 
Factors (CNFs) 
E. coli, Yersinia 
pseudotuberculos
is 
Rho GTPases 
(RhoA, Rac, 
Cdc42) 
Activation of Rho 
GTPases 
Flatau et al., 
(1997); Schmidt 
et al., (1997) 
Burkholderia 
Lethal Factor  
(BLF1) 
Burkholderia 
pseudomallei eIF4A 
Inactivation of 
helicase activity 
of translation 
factor 
Cruz-Migoni et 
al., (2011) 
VopC Vibrio parahaemolyticus 
Rho GTPases 
(Rac, Cdc42) 
Activation of Rho 
GTPases 
Zhang et al., 
(2012) 
PMT Pasteurella 
multocida 
Heterotrimeric G 
proteins (Gαi, 
Gαq/11, and 
Gα12/13) 
Activation of G 
protein signaling 
Orth et al., (2009) 
Cycle inhibiting 
factors (Cifs) 
E. coli, 
Burkholderia 
pseudomallei, 
Yersinia 
pseudotuberculos
is, Photorhabdus 
luminescens, 
Photorhabdus 
asymbiotica  
NEDD8 and 
ubiquitin 
Inactivation 
ubiquitin-
proteasome 
system 
Cui et al., (2010) 
OspI Shigella flexneri UBC13 Inactivation of E2 
ubiquitin 
conjugating 
activity of UBC13 
Sanada et al., 
(2012) 
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 Chapter 3 
P. syringae type III effector HopAF1 suppresses plant immunity by targeting the 
methionine recycling pathway 
Preface 
The following chapter will be submitted for publication at the completion of some 
additional experiments currently being performed by myself and our collaborator, Mark 
Banfield, at the John Innes Centre in Norwich, UK. We aim to submit this paper for 
publication in the next 2-3 months. Shahid Mukhtar performed the yeast two-hybrid screens 
and pairwise tests in which the initial interaction between HopAF1 and MTN1 was identified. 
I generated data for the rest of the figures, with the help of many resources, including the 
UNC Biology Imaging Core Facility, the UNC Macromolecular Interactions Facility, and the 
UNC Center for Structural Biology, along with input from members of the Dangl-Grant lab. In 
addition, I wrote the manuscript under the direction of my advisor, Jeff Dangl. 
I generated tools during the completion of this chapter that have contributed to other 
lab projects. I generated two Gateway-compatible vectors for estradiol-inducible expression 
of proteins tagged C-terminally with either citrine-HA or cerulean-HA. The former vector was 
published by Akimoto-Tomiyama et al., (Akimoto-Tomiyama et al., 2012) and I was included 
as 4th author on this paper for my contribution. pMDC7-cerulean-HA was also used in a 
publication (Roberts et al., 2013). Finally, a plasma membrane localization marker that I 
generated for confocal microscopy experiments, PLC2-YFP, contributed to work published 
in Gao et al (Gao et al., 2011). 
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Abstract 
Many plant pathogens, including Pseudomonas syringae, encode the type III 
secretion system for translocating effector proteins into the host during infection. Strains of 
P. syringae which are not capable of delivering the type III effectors are nonpathogenic. 
Therefore, the functions of type III effectors are essential for disease. Although several type 
III effectors have been demonstrated to block components of the plant defense response, 
the functions of most type III effectors during disease manifestation are largely unknown. 
Our lab is interested in the type III effector HopAF1, a type III effector that is present in 
eleven of the nineteen sequenced strains of P. syringae and other plant pathogens. 
Although the presence of HopAF1 in multiple strains of P. syringae suggests that it plays an 
important role in virulence, no function has yet been associated with HopAF1. We began to 
determine the function of HopAF1 with structure/function analyses. Using the BioInfoBank 
Meta Server and HHPred structural prediction programs and homology searches, we 
generated a tertiary structure model for HopAF1. These predictions suggest with high 
confidence that HopAF1 is structurally related to bacterial deamidase proteins. Deamidation, 
the irreversible substitution of an amide group with a carboxylate group, is the mechanism 
by which several bacterial virulence factors manipulate the activity of a specific substrate. To 
identify a potential target of the HopAF1 putative deamidation activity, we employed a 
stringent yeast two-hybrid screen and identified Arabidopsis methylthioadenosine 
nucleosidase (MTN1) as a putative target of HopAF1. This interaction, which we extended to 
include Arabidopsis MTN2, was confirmed in planta using coimmunoprecipitations and 
bimolecular fluorescence complementation assays. MTNs are enzymes in the methionine 
recycling cycle, which is a cycle essential for high levels of ethylene biosynthesis. Ethylene 
is a key plant hormone for plant developmental processes, such as senescence and 
flowering. Ethylene is also induced during PTI. Therefore, we hypothesized that HopAF1 
inhibits PTI by manipulating MTNs and levels of ethylene in plants. To this end, we used gas 
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chromatography to measure ethylene biosynthesis in plants treated with bacterially-
delivered HopAF1. We determined that HopAF1 inhibits ethylene biosynthesis in a manner 
dependent on putative catalytic residues. Additionally, Yang cycle mutants mtn1 mtn2 and 
mtk are more susceptible to weak pathogens. This data is consistent with the idea that 
HopAF1 targets a novel component of the plant immune system, the Yang cycle. Additional 
work on this project includes determining the enzymatic activity by which HopAF1 inhibits 
MTN1 and MTN2. 
Introduction 
P. syringae is a Gram negative bacterium that causes disease in agronomically 
important crops such as tomatoes, tobacco, and beans and the model plant, Arabidopsis 
thaliana. P. syringae uses the type III secretion system (T3SS) to inject type III effector 
(T3E) proteins into the host to cause disease in plants. P. syringae mutants lacking the type 
III secretion system lack the ability to cause disease in hosts, meaning that the type III 
secretion system is its main virulence determinant (Lindgren et al., 1986). 
The immune response that plants use to protect themselves against pathogens 
consists of multiple stages. The first line of defense begins with transmembrane pattern 
recognition receptors (PRRs) perceiving conserved molecular patterns from pathogens 
called pathogen-associated molecular patterns (PAMPs). Because these microbial 
signatures are not limited to pathogenic microbes, they are often referred to as microbial-
associated molecular patterns or MAMPs. For the purposes of this chapter, we will use the 
terms PAMPs. PAMPs are often highly conserved across a wide range of microbes, fulfill a 
function essential to the pathogen’s lifecycle, and yet are not present in the host (Boller and 
Felix, 2009). Common bacterial PAMPs are lipopolysaccharide, peptidoglycan, elongation 
factor Tu (EF-Tu), and flagellin (Boller and Felix, 2009). A 22 amino acid peptide derived 
from a conserved region of the amino terminus of bacterial flagellin (flg22) is sufficient for 
recognition by host PRR, FLS2 (Felix et al., 1999; Gomez-Gomez and Boller, 2000). This 
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leads to a downstream signaling cascade that includes many components such as an 
increase in callose deposition, up-regulation of defense gene expression and an increase in 
ethylene biosynthesis. 
The second line of the plant immune system is activated by the recognition of 
pathogen effectors by plant disease resistance gene products. Plants use disease 
resistance (R) proteins, which often referred to as NB-LRR, or NLR, proteins due to their 
domain architecture to detect effectors from a wide variety of plant pathogens. The 
recognition of the presence of the effector, or more commonly the effect of an effector on a 
specific host protein, that leads to effector-triggered immunity or ETI. An enhanced and 
accelerated cell death response called the hypersensitivity response (HR) is an easily visible 
phenotype often associated with ETI (Jones and Dangl, 2006).  
Plant hormones are also key components of the plant immune response. There is 
significant cross-talk between the three main stress hormones in plants, salicylic acid (SA), 
jasmonic acid (JA), and ethylene that allow the plant to regulate its response to various 
classes of pathogen and herbivores. As such, recently it has become clear that the 
manipulation of plant hormone homeostasis is an important target of T3Es. For example, he 
P. syringae T3E HopI1 suppresses SA accumulation (Jelenska et al., 2007). Additionally, 
AvrPtoB stimulates ABA biosynthesis and ABA responses that antagonize SA biosynthesis 
and SA-mediated defenses (de Torres-Zabala et al., 2007). AvrRpt2 alters the auxin 
physiology to promote host susceptibility (Chen et al., 2007). XopD, a Xanthomonas 
campestris pv. vesicatoria T3E, was recently found to target a tomato ethylene response 
factor (ERF) called SIERF4. SIERF4 mutants display reduced ethylene levels and an 
increase in susceptibility to Xcv (Kim et al., 2013), supporting the hypothesis that ethylene is 
involved in plant defense. 
Ethylene is a key component of the PTI response. Ethylene accumulation up-
regulates the expression of pathogenesis-related (PR) proteins and increases the 
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accumulation of hydroxyproline-rich, cell-wall strengthening proteins (Ecker and Davis, 
1987; Penninckx et al., 1998). Ethylene also increases SA-induced expression of PR-1 
(Lawton et al., 1994). Furthermore, ethylene directly up-regulates the expression of FLS2. 
FLS2 transcription is directly controlled by binding of EIN3/EIL1/EIL2 to its promoter and in 
ethylene insensitive mutants (ein2) seedlings, FLS2 expression, and FLS2 protein 
accumulation are suppressed. As a result, ein2 plants are more susceptible to weakened 
strains of P. syringae (Boutrot et al., 2010; Mersmann et al., 2010). 
HopAF1 was identified as a T3E in P. syringae pv. tomato DC3000 (Pto DC3000) 
and P. syringae pv. phaseolicola 1448A race 6 via its HrpL-dependent transcriptional 
induction, a loosely defined N-terminal translocation signal sequence, and the ability to be 
translocated into plant cells (Chang et al., 2005). HopAF1 is confirmed to be present in 11 of 
19 strains of P. syringae (Baltrus et al., 2011). There are also HopAF1 orthologs in other 
plant pathogens, such asAvrXv3 from Xanthomonas campestris  pv. vesicatoria (Astua-
Monge et al., 2000), Ralstonia solanacearum, Pseudomonas savastoni, and Aave_1373 
from Acidovorax citrulli (Studholme et al., 2010). The presence of HopAF1 in multiple strains 
of P. syringae and other plant pathogens suggests an important role in virulence. 
The goal of this study was to determine the role of HopAF1 in P. syringae infections. 
We found that the C-terminal domain of HopAF1 is predicted to be structural homologous to 
bacterial deamidases, members of the papain-like superfamily. The C-terminus of HopAF1 
also contains conserved putative catalytic residues in the predicted catalytic fold. HopAF1 
inhibits PTI responses in a manner dependent on these putative catalytic residues. HopAF1 
inhibits high levels of ethylene biosynthesis, also in a manner dependent on its putative 
catalytic activity. HopAF1 interacts with Arabidopsis methylthioadenosine nucleosidases 
(MTN) at the plant plasma membrane. These Yang cycle proteins are required for recycling 
methionine to supplement de novo methionine biosynthesis. We demonstrated that the 
Yang cycle is required during high levels of ethylene biosynthesis during pathogen attack. In 
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sum we demonstrated that HopAF1 is a key virulence factor of P. syringae and also 
demonstrated the role of the Yang cycle and ethylene in the PTI. 
Results 
HopAF1 is a highly conserved type III effector with a putative C-terminal catalytic domain. 
To determine if the structure of HopAF1 might suggest an enzymatic activity, we 
used the BioInfoBank metaserver and HHPred structural prediction programs to generate a 
structure prediction for HopAF1 from P. syringae pv. tomato DC3000 (Bujnicki et al., 2001; 
Soding et al., 2005). The predicted structure of the full length HopAF1 protein did not have 
homology to any known protein structure. However, when the C-terminus of HopAF1 
(residues 130-284) was queried, the homology searches predicted with high confidence that 
the HopAF1 C-terminus is structurally related to CheD, a single-domain chemotaxis protein 
encoded by Thermotoga maritima (Figure 3.1A) (Chao et al., 2006). We validated our 
HopAF1 model using Verify3D (Eisenberg et al., 1997). 
We also generated structural models for all HopAF1 family members individually and 
found that each, except for the Acidovorax allele which has a C-terminal truncation, contains 
a predicted secondary structure with homology to CheD (Figure 3.1B). We specifically 
focused on the divergent allele AvrXv3 from Xanthomonas campestris, which triggers HR in 
tomato and pepper plants (Astua-Monge et al., 2000). Although HopAF1 and AvrXv3 are 
only 27% identical, structural modeling of AvrXv3 also predicts that this protein has 
structural homology to CheD (Figure 3.1C). 
CheD is a deamidase that activates methyl-accepting chemotaxis proteins (MCPs) 
(Chao et al., 2006). CheD is structurally related to the Cytotoxic Necrotizing Factor (CNF) 
family of bacterial deamidases (Flatau et al., 1997; Schmidt et al., 1997). Deamidation is the 
irreversible mutation of asparagine and glutamine residues to aspartic acid and glutamic 
acid, respectively. Deamidation is a posttranslational modification utilized by multiple 
bacterial virulence factors to modify the function of eukaryotic host target proteins 
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(Washington et al., 2013). The catalytic domains of all known bacterial deamidases contain 
homology to papain-like structures (Washington et al., 2013). Therefore, we hypothesized 
that the HopAF1 orthologs possess enzymatic activities associated with the papain-like 
superfamily of enzymes, potentially deamidation. Bacterial deamidases require a histidine 
and cysteine residue in their catalytic pocket for activity. We demonstrated that the C-termini 
of both HopAF1 and AvrXv3 are predicted to form a catalytic pocket in which the invariant 
catalytic residues for deamidation, cysteine and histidine, are present (Figure 3.1A,B). 
Interestingly, these residues are conserved among all known HopAF1 orthologs, including 
the divergent family members such as AvrXv3 (Figure 3.2). Therefore, we predicted that 
these residues are likely catalytic and critical for the enzymatic function of HopAF1. 
The role of the third catalytic residue of deamidases is to coordinate the imidazole 
ring of histidine to ensure optimal orientation of the thiolate-imidazolium pair; therefore these 
residues are required for function. The third residue of the CheD catalytic triad is T27 (Figure 
3.1A). There is no threonine at this position in HopAF1 family members. However, adjacent 
to the position of T27, there is a conserved aspartic acid, D154, in HopAF1 (Figure 3.1A). 
We hypothesize that this residue may be involved in catalytic activity. Unfortunately, 
structural modeling predicts this residue is present on a flexible loop and therefore, we are 
not confident about the exact position of D154. Since the cysteine and histidine are 
invariant, we did not mutate the predicted third catalytic residue of HopAF1. We simply 
focused on the invariant putative catalytic residues, cysteine and histidine, in further 
analyses of HopAF1 function. 
HopAF1 blocks flg22-induced PTI and this requires its putative catalytic residues. 
Many T3Es block PAMP-triggered immunity (PTI) and thereby contribute to bacterial 
virulence (Block and Alfano, 2011). To determine if HopAF1 plays a role in virulence, we 
obtained a Pto DC3000 derivative in which the HopAF1 gene has been disrupted (Jamir et 
al., 2004). We did not observe a significant growth defect of Pto DC3000 in the absence of 
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HopAF1 (data not shown), therefore we decided to see if HopAF1 could enhance the growth 
of a weak pathogen. To this end, we generated wild-type HopAF1 transgenic lines in the 
wild-type Arabidopsis Col-0 background. We also generated the putative catalytic dead 
version of the HopAF1 transgenic lines, by mutating both the C159 and H186 to alanine 
(HopAF1C159AH186A). Conditional expression of HopAF1 wild-type and HopAF1C159AH186A was 
evident by 6 hours after estradiol induction and was maintained for 48 hours. 
The removal of 28 T3Es by sequential mutagenesis from Pto DC3000 transformed 
this virulent strain into a weakly pathogenic derivative called Pto DC3000D28E (Cunnac et 
al., 2011). To determine if HopAF1 inhibits PTI, we measured the growth of Pto 
DC3000D28E in our transgenic lines 24 hours after induction of HopAF1 expression by 
estradiol treatment. We hand inoculated Pto DC3000D28E into Col-0 and the two 
independent HopAF1 transgenic lines for both wild-type HopAF1 and HopAF1C159AH186A. We 
observed enhanced growth of Pto DC3000D28E on HopAF1-expressing transgenic lines 
compared to Col-0, demonstrating that HopAF1 expression allowed for the enhanced growth 
of a weak pathogen when overexpressed in planta (Figure 3.3A). The increase in bacterial 
growth in the transgenic lines correlates with an increase in disease symptoms (Figure 
3.3B). Importantly, the growth of Pto DC3000D28E on transgenic lines expressing the 
putative catalytic dead HopAF1 was similar to that on Col-0, indicating that the enhanced 
growth of a weak pathogen on HopAF1 transgenic lines was dependent on the putative 
catalytic residues of HopAF1 (Figure 3.3A,B). The expression of HopAF1 in these lines was 
confirmed by western blots (Figure 3.3C). 
The pretreatment of Arabidopsis plants with flg22 induces PTI and diminishes 
susceptibility to subsequent infection with virulent pathogens, such as Pto DC3000 (Zipfel et 
al., 2004). To further test our hypothesis that HopAF1 inhibits PTI, we examined flg22-
induced disease resistance in Col-0 and the HopAF1 transgenic lines. After flg22 treatment, 
we observed reduced growth of Pto DC3000 on Col-0 compared to untreated plants (Figure 
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3.4A). This effect was suppressed in transgenic Col-0 plants expressing HopAF1, but not in 
transgenic Col-0 plants expressing the HopAF1 putative catalytic dead protein (Figure 3.4A). 
Because Pto DC3000 is a highly virulent pathogen, HopAF1 transgenic plants are not more 
susceptible to Pto DC3000 than Col-0. Expression of HopAF1 in the transgenic lines in 
these experiments was also confirmed (Figure 3.4B). We conclude that HopAF1 suppresses 
flg22-induced PTI in a manner dependent on its putative catalytic residues. 
HR triggered by AvrXv3 in tomato is also dependent on its putative catalytic residues. 
AvrXv3 is recognized by, and elicits an HR-response in, tomato cultivar Florida 216 
(Fla 216) but not Florida 7060 (Fla 7060) (Astua-Monge et al., 2000). In order to determine if 
the putative catalytic residues of AvrXv3 are required for recognition and HR, we generated 
clones that allowed the constitutive overexpression of wild-type AvrXv3 and the AvrXv3 
putative catalytic residue mutant, AvrXv3H126A, with a C-terminal myc tag. We transiently 
expressed AvrXv3 wild type and mutant in both tomato cultivars via Agrobacterium mediated 
T-DNA transfer, we measured their expression by western blot, and scored for HR. Wild-
type AvrXv3, but not AvrXv3H126A, triggered HR on Fla 216 (Figure 3.5A). As expected, we 
did not observe HR on Fla 7060 (data not shown). All clones were expressed (Figure 3.5B). 
These data suggest that the recognition of AvrXv3 in tomato requires its putative catalytic 
residues. 
HopAF1 is targeted to the plasma membrane via acylation. 
The N-termini of multiple HopAF1 orthologs contain putative sites for myristoylation 
and palmitoylation (Figure 3.2). Myristoylation is a eukaryotic-specific posttranslational 
modification that is used often in combination with palymitoylation to target proteins stably in 
the plasma membrane lipid bilayer (Resh, 2006). Multiple P. syringae type III effectors utilize 
these modes of acylation to localize to the plasma membrane once injected into the plant 
cell (Dowen et al., 2009; Lewis et al., 2008; Nimchuk et al., 2000; Robert-Seilaniantz et al., 
2006; Shan et al., 2000). 
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We predicted that HopAF1 G2 and C4 are myristoylated and palmitoylated, 
respectively, to target HopAF1 to the plasma membrane. To test this hypothesis, we 
generated an acylation minus HopAF1 variant, HopAF1G2AC4S. For the HopAF1 orthologs 
that lack the putative acylation sequence, such as AvrXv3, we predicted that they will 
localize to the cytoplasm (Figure 3.2). We used confocal microscopy to detect the 
localization of transiently expressed estradiol-inducible HopAF1 and AvrXv3 in N. 
benthamiana. Both proteins were tagged on the C-terminus with a cerulean-HA tag. To 
avoid aberrant protein localization, we determined the lowest amount of Agrobacterium and 
estradiol necessary to detect HopAF1 via western blot (Figure 3.6A). We also confirmed that 
we were assaying the localization of HopAF1 and not free, soluble cerulean (Figure 3.6B). 
We used a plasma membrane marker, PLC2-YFP, as a plasma membrane localization 
control  (Otterhag et al., 2001). HopAF1 is localized at the plasma membrane and co-
localizes with PLC2 (Figure 3.7A). However, the acylation minus variant was localized in the 
plant cell cytoplasm, where it co-localized with free YFP, a marker for nucleocytoplasmic-
localized proteins (Figure 3.8A,B,C). Similar to the acylation minus HopAF1 variant, AvrXv3 
is found in the cytoplasm (Figure 3.7A). Both of the putative catalytic dead variants, 
HopAF1H186A and AvrXv3H126A, remained localized to the plasma membrane, suggesting that 
the putative catalytic activity of HopAF1 orthologs is not required for localization (Figure 
3.7A). 
To confirm the confocal data, we performed cell fractionation assays with N. 
benthamiana tissues transiently expressing the same constructs described above. The 
control proteins, anti-APX and anti-H+-ATPase were used as controls for the soluble and 
membrane fractions, respectively, and confirm that the separation of the fractions was 
complete. Wild-type HopAF1 is detected in the microsomal fraction, which contains the 
plasma membrane, whereas the acylation minus variant of HopAF1 is solely in the soluble 
fraction (Figure 3.7B). AvrXv3 is also in the soluble fraction. Consistent with the confocal 
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results, HopAF1H186A and AvrXv3H126A remained localized to the microsomal and soluble 
fractions, respectively (Figure 3.7B). We conclude that HopAF1 is targeted to the plant 
plasma membrane via the acylation signal sequence and mutation of the putative catalytic 
residues does not affect this localization. 
HopAF1 associates with Arabidopsis MTN proteins at the plasma membrane. 
We identified Arabidopsis methylthioadenosine nucleosidase (AtMTN1; At4g38800) 
as a protein that interacts with HopAF1 in a yeast two-hybrid screen (Mukhtar et al., 2011). 
This interaction was confirmed with pairwise yeast two-hybrid assays (data not shown). 
Methylthioadenosine nucleosidases function in the methionine recycling pathway, also 
known as the Yang cycle (Figure 3.9A) (Miyazaki and Yang, 1987). In Arabidopsis, two 
proteins, MTN1 and MTN2 (67% identical), are responsible for methylthioadenosine 
nucleosidase activity (Park et al., 2009). The Yang cycle generates high levels of methionine 
to supplement de novo synthesis of methionine. This process is essential when levels of 
methionine are limiting (Burstenbinder et al., 2007). This may be the case, for example, 
during PTI. PTI results in the induction of high levels of ethylene, and methionine is the 
precursor for ethylene biosynthesis. Therefore, if de novo biosynthesis of methionine does 
not produce sufficient levels of methionine, the Yang cycle may be required for the PTI-
triggered induction of ethylene biosynthesis. We hypothesized that disrupting the function of 
the Arabidopsis MTNs would block ethylene biosynthesis induced by PTI. Additionally, we 
predicted that the virulence function of HopAF1 was to inhibit MTN function and block 
ethylene-dependent PTI. This hypothesis is consistent with the finding that the type III 
secretion system deficient mutant, Pto DC3000 hrcC, triggers the accumulation of high 
levels of ethylene; whereas Pto DC3000 does not (Figure 3.9B). This suggests that the one 
or more members of the suite of T3Es from Pto DC3000 can suppress ethylene 
accumulation. 
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To extend the yeast two-hybrid interaction, we performed co-immunoprecipitation 
studies using Agrobacterium-mediated transient expression assays in N. benthamiana 
leaves. We co-expressed myc-tagged HopAF1 with the putative targets, MTN1-HA or 
MTN2-HA. The cell lysates were incubated with anti-myc conjugated beads. Bound MTN 
proteins were then detected with anti-HA westerns. We detected both MTN1-HA and MTN2-
HA interacting with HopAF1-myc (Figure 3.10A). Furthermore, HopAF1H186A-4x-myc co-
immunoprecipated with MTN1-HA.The negative control demonstrates that there is very little 
non-specific binding of MTN1-HA to the anti-myc beads (Figure 3.10A). We conclude that 
HopAF1 also interacts with Arabidopsis proteins MTN1 and MTN2 when transiently 
overexpressed in N. benthamiana. 
Because HopAF1 is targeted to the plant plasma membrane, we predicted the 
plasma membrane to be the site of interaction with MTNs. This is consistent with literature 
showing that MTN1 can be found in the plant plasma membrane fraction and may interact 
with CBL3 in the plasma membrane (Marmagne et al., 2007; Oh et al., 2008). Therefore, 
MTN1 and MTN2 may be transiently tethered to the plant plasma membrane via protein-
protein interactions. 
We used confocal microscopy to determine if HopAF1 and MTN1 could interact at 
the plasma membrane. We performed bimolecular fluorescence complementation (BiFC) 
experiments using a Gateway BiFC vector set with ubiquitin promoters providing low but 
detectable levels of expression to minimize aberrant interactions due to over-expression 
(Grefen et al., 2010). We generated constructs with MTN1 and MTN2 fused at their C-
termini to the C-terminal half of YFP. HopAF1 variants were fused at the C-terminus to the 
N-terminal half of YFP. As a negative control, we assayed whether HopAF1 associated with 
known plasma membrane protein PLC2 (Otterhag et al., 2001). Reconstitution of YFP, 
resulting in a fluorescent signal emitting light at 514nm, occurred at the plasma membrane 
when wild-type HopAF1-nYFP was co-expressed in N. benthamiana cells with either MTN1-
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cYFP or MTN2-cYFP (Figure 3.10B). However, there was no reconstitution of YFP when 
HopAF1-nYFP was co-expressed with PLC2-cYFP (Figure 3.10B). Reconstitution at the 
plasma membrane was not dependent on the putative catalytic activity of HopAF1 (Figure 
3.10B). Consistent with the presence of Arabidopsis MTNs in the cytoplasmic fraction 
(Figure 3.5B, above), the acylation minus HopAF1G2AC4S-nYFP variant co-expressed with 
MTN1-cYFP or MTN2-cYFP reconstituted the YFP signal, but in the cytoplasm (Figure 
3.10B). We conclude that wild-type HopAF1 and Arabidopsis MTNs interact specifically at 
the plasma membrane, consistent with the demonstrated localization of HopAF1, and the 
observation that MTN1 and MTN2 may transiently localize to the plasma membrane via 
protein-protein interactions (Marmagne et al., 2007; Oh et al., 2008). 
HopAF1 inhibits PAMP-induced ethylene production in a manner dependent on its  
putative catalytic activity and MTN proteins. 
Recognition of flg22 triggers activation of a MAPK cascade that leads to an increase 
in ethylene biosynthesis (Felix et al., 1991a; Felix et al., 1991b; Liu and Zhang, 2004). In 
order to determine the effect of HopAF1 on PAMP-induced ethylene biosynthesis, we 
established a system with which we could both induce ethylene biosynthesis with PAMPs 
and measure the effect of HopAF1 on subsequent ethylene biosynthesis. 
To induce PAMP-mediated ethylene production, we used a P. fluorescens strain 
(Pfo-1) lacking known T3Es but engineered to carry a functional T3SS, as a delivery vehicle 
for PAMPs, and, if desired, specific T3Es (Thomas et al., 2009). Pfo-1 triggers an increase 
in ethylene production (Figure 3.11A). We transformed HopAF1 variants expressed from the 
native promoter into Pfo-1. All HopAF1 alleles are expressed equally in Pfo-1 and are 
capable of translocation via the type III secretion system, as assayed via their ability to 
deliver truncated ∆79’avrRpt2 to trigger an RPS2-dependent HR (Figure 3.11B,C) (Mudgett 
and Staskawicz, 1999). 
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HopAF1 inhibited the PAMP-induced ethylene biosynthesis compared to Pfo-1 and 
empty vector controls (Figure 3.12A). Inhibition of ethylene production required the HopAF1 
putative catalytic residue H186, supporting our hypothesis that HopAF1 inhibits MTN 
function with catalytic activity (Figure 3.12B). However, the inhibition of PAMP-induced 
ethylene production was not dependent on HopAF1 localization in the plasma membrane 
(Figure 3.12B). This is consistent with our finding (Figure 3.10B), and literature (Marmagne 
et al., 2007; Oh et al., 2008) showing that MTN1 and MTN2 localized to both the plasma 
membrane and the cytoplasm. 
HopAF1 phenocopies Yang cycle intermediate mutants for PAMP-induced increase in  
ethylene production. 
We predicted that HopAF1 suppression of PAMP-induced ethylene production would 
be phenocopied in mutants of Yang cycle intermediates. As noted above, there are two 
MTN paralogs in Arabidopsis, and it is likely that they function redundantly in the Yang cycle 
(Figure 3.9A). MTN activity is required for maximal ethylene biosynthesis in tomatoes 
(Kushad et al., 1985). The enzyme downstream of MTN in the Yang cycle, MTK, is also 
required for maximal levels of ethylene biosynthesis (Burstenbinder et al., 2007). We 
obtained Arabidopsis mtn1 and mtn2 mutants and generated anew the mtn1 mtn2 double 
mutant (Burstenbinder et al., 2010). We demonstrated that Pfo-1 induced high levels of 
ethylene in each mtn1 and mtn2 single mutant, consistent with these proteins functioning 
redundantly for Yang cycle-mediated PAMP-induced ethylene biosynthesis (Figure 3.13A). 
However, in both the mtk single mutant and the mtn1 mtn2 double mutant, Pfo-1 was unable 
to induce high levels of ethylene production, demonstrating that the Yang cycle is necessary 
for PAMP-induced ethylene production in this assay (Figure 3.13B). These results are 
consistent with our suggestion that HopAF1 can inhibit PAMP-induced ethylene biosynthesis 
through modulating or inhibiting the functions of Arabidopsis MTN1 and MTN2. 
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HopAF1 inhibits MTN1 activity in vitro in manner dependent on its putative catalytic  
residues. 
We used recombinant proteins purified from E. coli to determine if HopAF1 can 
inhibit MTN1 function directly. A protocol for purifying Arabidopsis MTN proteins from E. coli 
was previously established (Park et al., 2009; Park et al., 2006). To purify HopAF1, we 
generated N-terminal 6xHis fusion constructs for wild-type and putative catalytic dead 
HopAF1. Because the coding sequence of HopAF1 likely contains subdomains, we also 
generated 6xHisMBP-tagged truncations of HopAF1 to identify the minimal region of 
HopAF1 required for activity (Figure 3.14A). We used circular dichroism to confirm that 
MTN1, 6xHis-HopAF1, and 6xHis-HopAF1H186A are folded (Figure 3.14B). 
Using an established assay to measure the activity of MTN1 in vitro (Dunn et al., 
1994), we demonstrated that HopAF1 inhibited the ability of MTN1 to cleave its substrate 
(Figure 3.15A,B). However, HopAF1H186A was not able to inhibit MTN1 activity (Figure 
3.15B). Furthermore, the proposed catalytic domain of HopAF1 (residues 130-284) is 
sufficient to inhibit MTN1 function (Figure 3.15B). The ∆147HopAF1 truncated protein was 
not able to inhibit MTN1 function, suggesting that an essential part of the HopAF1 structure 
exists between residues 130 and 147 (Figure 3.15B). These in vitro data support our in 
planta findings that HopAF1 inhibits PAMP-induced ethylene biosynthesis by blocking MTN 
function. 
MTN1 and MTN2 play a role in innate immunity. 
To determine the role of MTNs in PTI, we assayed the susceptibility of mtn1 mtn2 
and mtk to infection with Pto DC3000D28E. As a control, we used the ein2 (Ethylene 
Insensitive 2) null mutant (Alonso et al., 1999). Ethylene insensitive mutants allow enhanced 
growth of weak pathogens and are defective in flg22-mediated priming of the immune 
system (Boutrot et al., 2010; Mersmann et al., 2010). We show that Yang cycle mutants, 
similar to ein2, are more susceptible to Pto DC3000D28E (Figure 3.16). Additionally, the 
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enhanced growth of Pto DC3000D28E in mtn1 mtn2 was similar to levels of the same strain 
observed in transgenic plants expressing wild-type HopAF1 (Figure 3.16). 
Discussion 
Many plant bacterial pathogens use type III effectors (T3Es) as their main virulence 
determinants. The type III secretion system is essential to the ability of these plant 
pathogens to cause disease on their hosts. As such, it is critical to understand which host 
cellular systems T3Es are targeting and how they are disrupting those systems. Additionally, 
we learn how these potent virulence factors, which are common among plant and animal 
pathogens, function. 
HopAF1 is a reasonably well conserved T3E. The presence of HopAF1 in multiple 
strains of P. syringae and other plant pathogens suggests an important role in virulence and 
we sought to define its specific molecular function. Here we report that HopAF1 contributes 
to P. syringae virulence and we propose a model (Figure 3.17), in which HopAF1 interacts 
with Arabidopsis Yang cycle proteins, MTN1 and MTN2, at the plant plasma membrane. 
HopAF1 inhibits PAMP-induced ethylene biosynthesis and the mtn1 mtn2 phenocopies the 
effect of HopAF1 on PAMP-induced ethylene biosynthesis. This is consistent with HopAF1 
inhibition of MTN1 activity in vitro. We have also demonstrated that MTN1 and MTN2, and, 
therefore the Yang cycle, are key components of the plant immune response. 
The role of ethylene in the plant defense response is well-documented, yet 
complicated because of the multiple, and sometimes conflicting, roles that ethylene plays. 
The contradictory results from pathology assays might result from differences in bacterial 
strains used and infection methods. Ethylene plays a role in defense against necrotrophs by 
antagonizing salicylic acid responses which are involved in defense against biotrophs 
(Robert-Seilaniantz et al., 2007). Ethylene is also required for symptom development during 
infection with virulent and avirulent pathogens (Bent et al., 1992). 
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However, more recently, it has been demonstrated in multiple studies that ethylene 
plays a significant role in defense against P. syringae. Ethylene directly controls FLS2 
expression by inducing the activation of the EIN3/EIL family of transcription facts which 
directly bind the FLS2 promoter (Boutrot et al., 2010). This leads to an increase in FLS2 
protein accumulation (Boutrot et al., 2010; Mersmann et al., 2010). Mutants deficient in 
ethylene signaling pathways, such as ein2, have reduced FLS2 transcript levels with or 
without flg22 treatment (Boutrot et al., 2010). This likely contributes to the susceptibility of 
ein2 to weakened plant pathogens such as P. syringae pv. tomato DC3000 
∆AvrPto/∆AvrPtoB (Mersmann et al., 2010). Furthermore, XopD desumoylates and 
represses an ethylene-responsive transcription factor and suppresses ethylene 
accumulation (Kim et al., 2013). Ethylene is required for the immune response against 
Xanthomonas campestris pv. vesicatoria (Kim et al., 2013). 
The role of the Yang cycle in PTI responses is thus far undocumented. This is likely 
due to the lack of the link between Yang cycle proteins and pathogen-induced ethylene 
accumulation in the literature. The Yang cycle kinase, MTK, was demonstrated to be 
required for accumulation of high level of ethylene by crossing mtk with an ethylene 
overproducing mutant, eto (Burstenbinder et al., 2007). This suggested that the Yang cycle 
is required for high levels of ethylene biosynthesis, such as that which occurs during PTI. 
However, subsequent papers have stated that the MTN proteins are not required for 
ethylene biosynthesis (Burstenbinder et al., 2010). Unfortunately, they did not investigate 
ethylene accumulation in the double mtn1 mtn2 mutant; nor did they attempt to induce high 
levels of ethylene accumulation (Burstenbinder et al., 2010). Therefore, the burden of proof 
was on us to demonstrate the requirement of MTN proteins for high levels of ethylene 
accumulation in Arabidopsis. This highlights the importance of the results in figure 13. We 
conclude that the Yang cycle is not required for steady-state levels of ethylene biosynthesis. 
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However, our results consistently show that Yang cycle proteins, MTN1 and MTN2 or MTK 
are required for the high levels of PAMP-induced ethylene biosynthesis. 
However, there are still some questions that remain unanswered. For example, are 
there other type III effectors from P. syringae pv. tomato DC3000 that inhibit ethylene 
accumulation? In figure 9, we demonstrate that the type III secretion system deficient 
mutant, Pto DC3000 hrcC, triggers the accumulation of high levels of ethylene; whereas Pto 
DC3000 does not. Assuming there is an equal presence of PAMPs associated with these 
pathogens, the likely conclusion is that the fully virulent Pto DC3000 is suppressing ethylene 
accumulation. Incorporation of the Pto DC3000∆HopAF1 mutant into this assay will help us 
discern whether or not other effectors are targeting ethylene accumulation. For example, if 
Pto DC3000∆HopAF1 accumulates ethylene similar to Pto DC3000 hrcC, HopAF1 is likely 
to be the only Pto DC3000 T3E that can inhibit ethylene biosynthesis. Conversely, if Pto 
DC3000∆HopAF1 still inhibits ethylene accumulation similar to Pto DC3000, there are still 
T3Es other than HopAF1 that can inhibit ethylene biosynthesis. 
Although we have predicted, based on structural modeling, that HopAF1 is a 
member of the family of bacterial toxins/effectors that are deamidases, we have not yet 
demonstrated that HopAF1 uses this activity to affect the function of Arabidopsis MTNs or 
any other proteins. We have, however, demonstrated that the ability of HopAF1 to block PTI, 
inhibit MTN1 function in vitro, and inhibit PAMP-induced ethylene biosynthesis is dependent 
on putative catalytic residues. This suggests that HopAF1 has enzymatic activity. We will 
attempt to determine the enzymatic function of HopAF1 using mass spectrometry to identify 
deamidation on MTN1 (see Chapter 4). Mass spec has been an invaluable tool in identifying 
posttranslational modifications on host proteins due to pathogen virulence proteins, such as 
type III effectors. However, identifying a 1 Dalton increase in the size of a target protein, 
such as would occur during deamidation, with mass spectrometry is not trivial. For this 
reason, we are collaborating with Mark Banfield, a biochemist at the John Innes Centre with 
108 
extensive experience with deamidases (Crow et al., 2012; Crow et al., 2009; Jubelin et al., 
2009). 
Multiple P. syringae T3Es target PTI signaling pathways using diverse biochemical 
mechanisms. In this study, we have described a new component of the plant innate immune 
system, the Yang cycle. Furthermore, we will continue to determine whether a unique 
biochemical mechanism, namely deamidation, is being utilized by the P. syringae T3E 
HopAF1 to target Arabidopsis Yang cycle proteins, MTN1 and MTN2. 
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Materials and Methods 
Plant Lines and Growth Conditions 
We used wild-type Arabidopsis thaliana ecotype Columbia (Col-0) and all mutant 
Arabidopsis lines we used are in the Col-0 background. For generation of transgenic 
estradiol-inducible HopAF1-cerulean-HA, HopAF1C159AH186A-cerulean-HA lines, the HopAF1 
coding sequences were cloned into the pMDC7-cerulean-HA Gateway-compatible vector 
(Akimoto-Tomiyama et al., 2012) and transformed into Agrobacterium GV3101. Arabidopsis 
transgenics were generated using Agrobacterium-mediated floral dip transformation (Clough 
and Bent, 1998). Hygromycin selection of transgenic plants was performed by growing the 
seedlings on plates with ½ MS media with 15 μM hygromycin in the dark for 3 days and then 
in light conditions for 10 days. mtn1-1 (Burstenbinder et al., 2010), mtn1-2 (Burstenbinder et 
al., 2010), mtn2-1 (Burstenbinder et al., 2010), mtn2-2 (Burstenbinder et al., 2010), mtn1-1 
mtn2-1 (Burstenbinder et al., 2010), mtk (Sauter et al., 2004), and ein2-5 (Alonso et al., 
1999) have previously been described elsewhere. Except where otherwise noted, plants 
were grow under controlled short day conditions (9 hours light, 21°C, 15 hours dark, 18°C). 
Tomato cultivars Florida 216 (Fla 216) and Florida 7060 (Fla 7060) are described elsewhere 
(Astua-Monge et al., 2000) and were grown in the greenhouse. Nicotiana benthamiana 
plants were also grown in the greenhouse. 
 
Immunoblot analysis of plant proteins 
Unless otherwise noted, total proteins were extracted by grinding either fresh tissue or 
tissue flash-frozen in liquid nitrogen in a buffer containing 50 mM Tris-HCl pH 8.0, 1% SDS, 
1 mM EDTA pH 8.0, 14 mM β-mercaptoethanol, and protease inhibitor cocktail.  Samples 
were incubated on ice for 20 minutes and then the cell debris was pelleted by centrifuging 
the samples for 15 minutes at 20,800 g at 4°C. The supernatant was separated and 
quantified using the Bradford reagent. Protein was separated on 12% SDS-PAGE gels and 
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transferred to a nitrocellulose membrane. Western blots were performed using standard 
methods. Anti-HA (Santa Cruz Biotechnology) antibody was used at a 1:5000 dilution, anti-
APX (Agrisera) was used at a 1:5000 dilution, and anti-H+-ATPase (Agrisera) was used at a 
1:1000 dilution. Anti-myc polyclonal antisera was used at a 1:5 dilution. Anti-MTN1 and anti-
MTN2 were used at a 1:5000 dilution (Burstenbinder et al., 2010). 
 
Homology Modeling 
We initially detected the homology with the C-terminal domain of HopAF1 and CheD by 
querying the BioInfoBank Institut’s Metaserver and the HHPred structural prediction 
programs (Bujnicki et al., 2001; Soding et al., 2005). The 3-D model for the HopAF1 C-
terminus structure based on the Thermotoga maritima CheD (PDB 2F9Z) structure was 
generated with MODELLER (Sali and Blundell, 1993). The validity of the HopAF1 structural 
model was assessed using Verify3D (Eisenberg et al., 1997). Graphical images and 
structural alignments were produced with Pymol. 
 
P. syringae pv. tomato DC3000D28E Growth Curve Assay 
Leaves of five-week-old plants were hand inoculated with 1x105 cfu/mL of P. syringae pv. 
tomato DC3000D28E (Cunnac et al., 2011). Leaf bacterial populations were determined the 
day of inoculation and three days post-inoculation. Each data point consisted of six 
replicates. Plants expressing either estradiol-inducible HopAF1-cerulean-HA or estradiol-
inducible HopAF1C159AH186A-cerulean-HA were sprayed with 20 μM estradiol 24 hours before 
hand inoculations. 
 
Flg22-protection Growth Curve Assay 
Leaves of five-week-old plants were sprayed with 20 μM estradiol 12 hours before flg22 
infiltration. Plants were infiltrated with 1 μM flg22 or water 24 hours before infiltrating with 
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1x105 cfu/mL P. syringae pv. tomato DC3000. Leaf bacterial populations were determined at 
the indicated times. Each data point consisted of six replicates. 
 
Transient expression of AvrXv3 in tomato 
The coding sequences of AvrXv3 and AvrXv3H126A were cloned in the binary Gateway 
vector, pGWB17, which carries a C-terminal 4x-myc tag. Triparental mating was used to 
transfer this construct to Agrobacterium strain C58C1. For transient expression of AvrXv3 in 
tomato plants, the strains expressing AvrXv3 variants were grown overnight in LB media at 
28°C. The bacteria were centrifuged at 6800 g for 5 minutes and resuspended in 10 mM 
MgCl2 at an OD of 0.1. Fully expanded leaves were infiltrated with the bacterial strains and 
maintained in the greenhouse for 48 hours (immunoblot samples) or 72 hours (HR). 
Immunoblot analysis of protein samples was completed as previously described. 
 
Cell fractionations 
200 mg of tissue was flash-frozen in liquid nitrogen and ground in sucrose buffer (20 mM 
Tris-HCl pH 8.0, 0.33M sucrose, 1 mM EDTA pH 8.0, 5 mM DTT, plant protease inhibitors 
cocktail). The homogenate was centrifuged for 10 minutes at 2000 g at 4°C. The 
supernatant was collected as the total fraction. A portion of the total fraction was spun again 
for 30 minutes at 20,000 rpm at 4°C. The supernatant from this spin was collected as the 
soluble fraction. The pellet, which became the microsomal fraction, was resuspended in 
equal volumes of sucrose buffer. 
 
Agrobacterium-mediated transient transformations in N. benthamiana 
2 mL of overnight cultures were centrifuged at 10,600 g for 1 minute at room temperature. 
Cultures were resuspended in induction media containing 10 mM MgCl2 and 10 mM MES. 
Cultures were re-centrifuged and then resuspended in infiltration media plus 100 μM 
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acetosyringone and agitated at room temperature for 1 hour. Cultures were diluted to the 
appropriate concentrations for each experiment and hand-infiltrated into fully expanded 
Nicotiana benthamiana leaves. 
 
Coimmunoprecipitation 
For co-immunoprecipitation experiments we generated 35S::MTN1-HA, 35S::MTN2-HA, 
35S::HopAF1-myc, 35S::HopAF1H186A-myc using the Gateway constructs pGWB14 (C-
terminal 3x-HA tag) and pGWB17 (C-terminal 4x-myc tag). Constructs were infiltrated at 
concentrations of 0.2 OD each with 0.1 OD P19 (Voinnet et al., 2003). Samples were 
collected and flash-frozen in liquid nitrogen. Protein was ground in lysis buffer (20 mM Tris-
HCl pH 8.0, 1 mM EDTA pH 8.0, 150 mM NaCl, protease inhibitor cocktail), centrifuged for 
15 minutes at 6000 g in 4°C. The supernatant was diluted to a concentration of 2 mg/mL.  
50 μL of anti-myc beads was added to the protein sample and incubated at 4°C for 4 hours 
with gentle agitation. The bound protein complexes were washed in extraction buffer (20 
mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 300 mM NaCl) and eluted in pre-warmed 6X SDS-
PAGE loading buffer. The input and bound proteins were analyzed by SDS-PAGE and 
immunoblot analysis. 
 
Subcellular localization 
HopAF1, HopAF1H186A, HopAF1G2AC4S, AvrXv3, and AvrXv3H126A coding sequences were 
cloned into the Gateway-compatible pMDC7-cer-HA vector (Akimoto-Tomiyama et al., 2012) 
and transferred into Agrobacterium strain C58C1 by triparental mating. Agrobacterium-
mediated transformations into Nicotiana benthamiana leaves were performed as described 
above. Agrobacterium strains expressing HopAF1, HopAF1H186A, HopAF1G2AC4S, AvrXv3, 
and AvrXv3H126A were inoculated at an OD of 0.01 in combination with the PLC2 plasma 
membrane marker at 0.1 OD. Three days post-infiltration, leaves were sprayed with 5 μM 
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estradiol for 3 hours. The subcellular localization of the proteins was observed using a Zeiss 
LSM 710 confocal scanning laser microscope. The plasma membrane marker, PLC2-YFP, 
was generated by cloning the PLC2 ORF from Col-0 cDNA into the pGWB41 Gateway 
vector. 
 
Bimolecular fluorescence complementation 
HopAF1 and MTN1 coding sequences were cloned into bimolecular fluorescence (BiFC) 
constructs that contain an ubiquitin promoter (Gehl et al., 2009). HopAF1-nYFP, 
HopAF1H186A-nYFP, HopAF1G2AC4S-nYFP were transiently co-expressed with MTN1-cYFP, 
MTN2-cYFP, and PLC2-cYFP in N. benthamiana leaves using Agrobacterium-mediated 
transient transformation. Strains expressing either HopAF1, MTN1, MTN2, or PLC2 were 
inoculated at 0.4 OD with 0.1 OD of P19 (Voinnet et al., 2003). 3 days after infiltration, 
confocal microscopy was used to image the reconstituted YFP signal. 
 
HopAF1 purification 
N-terminal 6xHis affinity tag constructs for HopAF1 and HopAF1H186A were generated by 
ligation independent cloning (Aslanidis and de Jong, 1990). 6xHisMBP-∆130HopAF1 and 
6xHisMBP-∆147HopAF1 were generated by cloning a TEV protease cleavage site onto the 
N-terminus of the truncated HopAF1 ORFs and cloning them into the Gateway-compatible 
pDEST-HisMBP vector. 
 
All HopAF1 bacterial expression constructs were transformed into ArticExpress (DE3) RIL 
(Agilent) cells. To initiate protein production, overnight cultures were used to inoculate 5 L of 
LB media containing 100 μg/mL ampicillin at a 1:200 dilution. Cells were grown at 28°C until 
the OD reached 0.6-0.8 and then the temperature was reduced to 14°C. Protein production 
was induced with 1 mM IPTG and cells continued to grow overnight at 14°C. 
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Purification of 6xHis-HopAF1 and 6xHis-HopAF1H186A involved affinity purification on a 
HisTrap column followed additional purification with the HiPrep 16/60 Sephacryl S-200 High 
Resolution (GE Healthcare) size exclusion column. The HopAF1 fractions that were not in 
the void volume were collected for in vitro assays. 
 
Purification of 6xHisMBP-∆130HopAF1 and 6xHisMBP-∆147HopAF1 also began with a His 
affinity purification. This was followed by dialysis into TEV cleavage buffer (20 mM Tris pH 
8.0, 50 mM NaCl, 1 mM DTT, and 0.5 mM EDTA) and TEV cleavage at room temperature 
for 6 hours. Reverse affinity chromatography was used to collect the HopAF1 truncations 
into relatively pure fractions. These fractions were dialyzed into anion exchange buffer (20 
mM Tris pH 8.0, 50 mM NaCl overnight at 4°C and further purified with the anion exchange 
HiLoad 16/10 Q sepharose column (GE Healthcare). Size exclusion chromatography using 
a HiPrep 16/60 Sephacryl S-200 High Resolution column (GE Healthcare) resulted in 
monodispersed protein. 
 
MTN1 purification 
MTN1 (At4g38800) was purified as previously described (Park et al., 2009). In brief, a 
PreScission Protease cleavage site was cloned onto the N-terminus of MTN1, which was 
then cloned into the Gateway vector pDEST15, which carries an N-terminal glutathione S-
transferase (GST) tag. This clone was transformed into Novagen® Rosetta E. coli 
BL21(DE3) cells. A 5 mL overnight culture was used to inoculate 1L of LB media containing 
100 μg/mL ampicillin. Cells were grown at 37°C to an OD of 0.6-0.8. The temperature was 
reduced to 22°C. Protein production was induced with 1 mM IPTG and cells continued to 
grow at 22°C overnight. MTN1 was purified with a GST affinity purification step followed by 
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PreScission Protease cleavage and reverse chromatography to isolate “free” MTN1 in the 
flow through fractions. 
 
MTN activity assays 
MTN activity assays were performed as previously described (Dunn et al., 1994). Briefly, 
reactions were carried out in 50 mM imidazole pH 8.0, 0.28 units of grade III buttermilk 
xanthine oxidase, 1 mM 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride 
(INT) and 0.12 μg recombinant MTN1. The reaction was monitored at 470 nm on a Tecan 
GENios microplate reader (Tecan, Ltd., Switzerland) for 15 minutes with 1 minute 
increments. Changes in absorbance were converted to the amount of adenine released 
using the molar absorption coefficient (15,400 M-1 cm-1 at pH 8.0). To generate the 
Michaelis-Menten plot, the experiment was completed with a range of MTA concentrations 
(0 μM MTA – 150 μM MTA).  Specific activity assays were completed with 50 μM MTA. All 
enzyme reactions had a final volume at 800 μL and were performed in triplicate at 25°C. All 
reagents for the kinetic assay were purchased from Sigma-Aldrich Chemicals (St. Louis, 
MO). 
 
Ethylene measurements 
Three-week-old seedlings were vacuum-infiltrated with Pfo-1 strains measured at 0D 0.04 in 
10 mM MgCl2. After three hours, the fresh weight of the seedlings was measured. Seedlings 
were sealed into gas chromatography vials and ethylene was allowed to accumulate for 24 
hours. Ethylene accumulation was measured using a Clarus 500 gas chromatograph (Perkin 
Elmer, USA). A pure ethylene gas control was used in each experiment. Each data point 
represents 3 to 4 replicates. 
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Induction of native promoter HopAF1 in minimal media 
Genomic clones of wild-type HopAF1, HopAF1H186A, and HopAF1G2AC4S, including the native 
promoter with a hrp-box, were cloned into a Gateway-compatible vector, pJC531, carrying a 
C-terminal HA-tag. This clone was transformed into P. fluorescens, a strain engineered to 
express the T3SS (Thomas et al., 2009). Strains were spread onto KB plates overnight and 
resuspended in minimal media (7.8 mM ammonium sulfate, 50 mM potassium phosphate, 
1.7 mM sodium chloride, 1.7 mM NaCl and 10 mM mannitol) at an OD of 0.02. After growth 
in 28°C for 12 hours, 2 mL of each cultures was centrifuged at room temperature for 5 
minutes at 8600 g. The pellet was resuspended in 100uL of 6X SDS loading buffer, boiled 
for 10 minutes, and 10 μL was loaded onto SDS-PAGE gel. 
 
Circular dichroism 
6xHis-HopAF1, 6xHis-HopAF1H186A, and MTN1 were purified as described above and 
dialyzed into a buffer containing 20 mM sodium phosphate pH 7.4, 150 mM NaF. Samples 
of approximately 0.4 mg/mL (HopAF1 variants) or 0.5 mg/mL (MTN1) were placed in a 1.0 
mm cuvette. Molar ellipticity measurements were collected at 25°C from 185 nm to 260 nm 
on a Chirascan Plus (Applied Photophysics, Ltd, Surrey, United Kingdom). 
 
Generating the mtn1 mtn2 double mutant 
In order to generate the mtn1 mtn2 double mutant, which is sterile (Burstenbinder et al., 
2010), we obtained and genotyped the previously described GABI Kat lines mtn1-2 and 
mtn2-2 (Burstenbinder et al., 2010). We crossed mtn1-2 and mtn2-2, selfed the resulting 
T1s and screened the T2s for lines which were homozygous for mtn1 and segregating mtn2. 
We maintained several stocks of these lines, which we sowed out and PCR genotyped to 
identify double homozygous plants at the time of experimentation. 
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Translocation Assay from Pfo-1 and trypan blue staining 
Genomic HopAF1 constructs were cloned into the pJC532, a Gateway-compatible vector 
carrying a C-terminal tag of the C-terminal 177 residues of the type III effector protein 
AvrRpt2, from which the N-terminal 79 amino acids of AvrRpt2 were deleted (‘∆79AvrRpt2) 
(Chang et al., 2005; Mudgett and Staskawicz, 1999). HopAF1-∆79AvrRpt2, HopAF1H186A-
∆79AvrRpt2, HopAF1G2AC4S-∆79AvrRpt2 were transferred into Pfo-1 using triparental 
mating. Sixteen leaves of Arabidopsis Col-0 were hand-infiltrated per strain and the HR was 
scored 26 hours post inoculation. The HR was compared to leaves infiltrated with Pfo-1 
alone or Pfo-1 carrying an empty vector.  
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Figures 
 
Figure 3.1. The predicted structure of HopAF1 exhibits structural homology to CheD, 
a bacterial deamidase. A) Homology model of HopAF1 reference allele (blue) from P. 
syringae pv. tomato DC3000 (Pto DC3000) residues 130-284 aligned with CheD (PDB 
2F9Z) (silver). The side chains of the putative catalytic residues of HopAF1, C159, H186, 
and D154, are highlighted in green. The side chains of the CheD catalytic residues are in 
silver. B) Independent homology models for the additional HopAF1 family members: P. 
syringae pv. maculicola M4 (teal), P. syringae pv. aceris (grey), P. syringae pv. lachrymans 
str. M302278 (green), and Acidovorax citrulli Aave_1373 (pink). HopAF1 from Pto DC3000 
is included in blue as a reference. C) Homology model of AvrXv3 from Xanthomonas 
vesicatoria (magenta) aligned with CheD (silver). Putative catalytic residues, C105 and 
H126, of AvrXv3 are highlighted in yellow and align with the catalytic residues of CheD 
(silver). 
.  
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Figure 3.2. Alignment of HopAF1 sequences from P. syringae pathovars and other 
plant  pathogens. Protein sequences from HopAF1 homologs from P. syringae pv. tomato 
DC3000 (accession no. NP_791393), P. syringae pv. aceris strain M302273 (accession no. 
WP_003402453), P.syringae pv. actinadae str. M02091 (accession no. WP_003381937), P. 
syringae pv. lachrymans str. M302278 (Lac106) (accession no. WP_0057667510), P. 
syringae pv.lachrymans str. M301315 (Lac107) (WP_005746129), P. syringae pv. 
maculicola M4 str. ES4326 (accession no. WP_007248647), P. syringae pv. mori str. 
301020 (accession no. WP_005752338), P. syringae pv. pisi (accession no. 
WP_003346247), P. syringae pv. phaseolicola 1448A race 6 (accession no. YP_273699), 
P.syringae pv. syringae B728A (accession no. YP_236881), P. syringae pv. tomato T1 
(accession no. EEB59276), Pseudomonas savastoni (accession no. YP_006961546), 
Ralstonia solanacearum str. Po82 (accession no. YP_006028103), Xanthomonas 
campestris pv. muscacearum (accession no. WP_010369035), Xanthomonas vesicatoria 
AvrXv3 (accession no. WP_008577605), and Acidovorax citrulli AAC00-1 Aave_1373 
(accession no. YP_969738) were aligned using VectorNTI AlignX. Amino acids with 80% 
identity are shaded in grey. Putative catalytic residues are highlighted in yellow. Sites for 
myristoylation and palmitoylation in denoted in red and orange, respectively. Residues 
highlighted in green highlight the beginning of the putative catalytic domain.  
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Figure 3.3. HopAF1 transgenic lines are susceptible to weak pathogens. A) Bacterial 
growth of P.syringae pv. tomato DC3000D28E (Cunnac et al., 2011) in Col-0 and two 
independent transgenic lines expressing either estradiol-inducible HopAF1-cerulean-HA or 
estradiol-inducible HopAF1C159AH186A-cerulean-HA was measured 0 and 3 days after hand 
inoculation with 1x105 cfu (colony-forming units)/mL bacteria. Transgene expression was 
induced with 20 μM estradiol 24 hours prior to bacterial inoculation. Error bars represent 
standard error (SEM). An analysis of variance (ANOVA) was performed among the day 3 
samples, followed by Tukey’s post-hoc analysis (p < 0.05). Groups that differ significantly 
are indicated with different letters. B) Disease symptoms in two independent lines of 
HopAF1-cerulean-HA and HopAF1C159AH186A-cerulean-HA were photographed 3 days after 
hand-inoculation with 1 x 105 cfu/mL of P. syringae pv. tomato DC3000D28E in HopAF1 
transgenic lines. C) Immunoblot analysis with anti-HA shows the expression of HopAF1-
cerulean-HA and HopAF1C159AH186A-cerulean-HA in transgenic plants 3 days after spray 
application of 20 μM estradiol. 
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Figure 3.4. Arabidopsis transgenic lines expressing wild-type HopAF1 inhibit flg22-
mediated protection against P. syringae pv. tomato DC3000. A) Col-0, estradiol-
inducible HopAF1-cerulean-HA, and estradiol-inducible HopAF1C159AH186A-cerulean-HA were 
sprayed with 20 μM estradiol for 12 hours and then infiltrated with 1 μM flg22 or water for 24 
hours prior to infiltration with 1x105 cfu/mL P. syringae pv. tomato DC3000. Bacterial growth 
was determined 0 and 3 days after bacterial inoculation. Error bars represent SEM. An 
ANOVA was performed among the day 3 samples, followed by Tukey’s post-hoc analysis (p 
< 0.05). Groups that differ significantly are indicated with different letters. B) Immunoblot 
analysis with anti-HA shows the expression of HopAF1-cerulean-HA and HopAF1C159AH186A-
cerulean-HA in transgenic plants 3 days after bacterial infiltration, which corresponds to 108 
hours (or 4.5 days) after estradiol induction.  
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Figure 3.5. HR triggered by AvrXv3 is dependent on putative catalytic residues. A) 
AvrXv3-4x myc and AvrXv3H126A-4x myc were transiently expressed in tomato cultivar Fla 
216. Cores containing both infiltrated and uninfiltrated tissue where removed from the 
tomato leaves 3 dpi and trypan blue staining was used to highlight the cell death response 
associated with HR. B) Anti-myc immunoblot analysis demonstrates the expression of 
AvrXv3-4x-myc and AvrXv3H126A-4x-myc in tomato cultivar Fla 216 dpi. Ponceau staining of 
the membrane indicates equal loading.    
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Figure 3.6. Establishing a system to study localization of transiently expressed 
HopAF1 in N. benthamiana. A) Levels of HopAF1-cerulean-HA transiently expressed in N. 
benthamiana were titrated by varying the concentration of estradiol (μM) and OD of 
Agrobacterium. Immunoblots with anti-HA were used to detect the expression of HopAF1-
cerulean-HA. N. benthamiana leaves were sprayed with 5 μM estradiol 3 days post-
infiltration with Agrobacterium and leaf samples were collected 3 hours after estradiol 
application for immunoblot analysis. B) Immunoblot analysis with anti-HA shows the 
expression of full-length HopAF1-cerulean-HA, HopAF1H186A-cerulean-HA, and 
HopAF1G2AC4S-cerulean-HA and the absence of free cerulean (black arrow) at approximately 
27 kDa. N. benthamiana leaves were sprayed with 5 μM estradiol 3 days post-infiltration 
with Agrobacterium. Protein samples were collected 3 hours after estradiol application. 
Ponceau staining indicates equal loading.  
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Figure 3.7. HopAF1 is targeted to the plasma membrane via acylation. A,B) Estradiol-
inducible HopAF1-cerulean-HA, HopAF1G2AC4S-cerulean-HA, HopAF1H186A-cerulean-HA, 
AvrXv3-cerulean-HA, and AvrXv3H126A-cerulean HA were expressed transiently in N. 
benthamiana using Agrobacterium-mediated transient transformations. Transgene 
expression was induced with 5 μM estradiol 3 days after bacterial infiltration. A) The 
localization of transiently expressed proteins was determined with scanning confocal laser 
microscopy 3 hours after estradiol induction in N. benthamiana epidermal cells. PLC2-YFP 
is a marker for the plasma membrane localization. Scale bars represent 20 μm. White 
arrowheads indicate the plasma membrane (PM), cytoplasmic streaming (CS), and nuclei 
(N). B) Cellular fractionations into total (T), soluble (S), and microsomal (M) fractions were 
performed. Equal cell equivalents were loaded onto SDS-PAGE gels followed by anti-HA 
immunoblots to detect the fractions with the expressed proteins of interest. Anti-APX and 
anti-H+-ATPase were included as controls for the soluble (S) and microsomal (M) fractions, 
respectively.  
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Figure 3.8. The acylation-minus variant of HopAF1 co-localizes with free YFP, a 
soluble protein. A-C) Estradiol-inducible HopAF1-cerulean-HA and HopAF1G2AC4S-
cerulean-HA were expressed transiently in N. benthamiana using Agrobacterium-mediated 
transient transformations. Transgene expression was induced with 5 μM estradiol 3 days 
after bacterial infiltration. A) The localization of transiently expressed proteins was 
determined with scanning confocal laser microscopy 3 hours after estradiol induction in N. 
benthamiana epidermal cells. Free YFP is a soluble protein and, therefore, can be used as a 
marker of the plant cytoplasm. Scale bars represent 20 μm. B) Merged image of estradiol-
inducible HopAF1-cerulean-HA and YFP. C) Merged image of estradiol-inducible 
HopAF1G2AC4S-cerulean-HA and YFP. White arrowheads indicate the plasma membrane 
(PM), cytoplasmic streaming (CS), and nuclei (N).  
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Figure 3.9. The Yang cycle contributes to ethylene biosynthesis, which is suppressed 
by Pto DC3000. A) In this figure adapted from Rzewuski et al., (Rzewuski et al., 2007) the 
relationship between the Yang cycle (also known as the methionine recycling cycle) and the 
phytohormone ethylene in Arabidopsis is highlighted. Arabidopsis MTN1 and MTN2 are two 
Yang cycle proteins. Both can catabolize MTA by cleaving the adenine to create the product 
MTR. MTR is then phosphorylated by the kinase MTK. MTNs also functions in a secondary 
pathway to recycle methionine, in which S-adenosylhomocysteine is its substrate. 
Methionine is a precursor for the ethylene biosynthesis pathway. It is important to note that 
recycling of methionine supplements the continual de novo synthesis of methionine. B) 
Arabidopsis seedlings were vacuum-infiltrated with multiple concentrations of P. syringae pv. 
tomato DC3000 and the type III secretion system deficient mutant, P. syringae pv. tomato 
DC3000 hrcC. 3 hours post infiltration, the fresh weight of 4 seedlings was measured and 
these seedlings were sealed in a vial for 24 hours before ethylene accumulation was 
measured. Error bars represent standard error and an ANOVA was performed, followed by 
Tukey’s post-hoc analysis (p < 0.05). Groups that differ significantly are indicated with 
different letters. 
127 
 
Figure 3.10. HopAF1 associates with Arabidopsis MTN proteins at the plasma 
membrane. A) Protein extracts from N. benthamiana leaves transiently expressing HopAF1-
4x-myc, HopAF1 H186A-4x-myc, MTN1-HA, and MTN2-HA were collected 3 days after 
infiltration and subjected to immunoprecipitation using anti-myc-coupled magnetic beads. 
400 μg of input and a 50x concentrated elution fraction were analyzed by anti-HA and anti-
myc immunoblots. B) HopAF1-nYFP, HopAF1H186A-nYFP, HopAF1G2AC4S-nYFP were 
transiently co-expressed with MTN1-cYFP, MTN2-cYFP, and PLC2-cYFP in N. benthamiana 
leaves using Agrobacterium-mediated transient transformation. 3 days after infiltration, 
confocal microscopy was used to image the reconstituted YFP signal. Scale bar represents 
50 μm. 
  
128 
 
Figure 3.11. Establishing P. fluorescens as a tool to determine the effect of HopAF1 
on PAMP-induced ethylene accumulation. A) This dose response curve demonstrates 
the increase in ethylene biosynthesis elicited by increasing concentrations of Pfo-1. B) Pfo-1 
expressing native promoter HopAF1 variants was inoculated into Col-0 leaves and observed 
after 24 hours. The ability to elicit an RPS2-dependent HR indicates translocation of the 
fusion proteins. The number of leaves in which HR was evident compared to the number of 
leaves inoculated is displayed next to representative leaves for each Pfo-1 inoculation. C) 
Expression of native promoter HopAF1 variants in Pfo-1 was induced with minimal media for 
12 hours and detected with anti-HA immunoblot. 
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Figure 3.12. HopAF1 inhibits PAMP-induced ethylene biosynthesis. A) Arabidopsis 
seedlings were vacuum-infiltrated with either MgCl2, Pfo-1, Pfo-1 carrying the empty vector 
(EV), Pfo-1 expressing HopAF1. 3 hours post infiltration, the fresh weight of 4 seedlings was 
measured and these seedlings were sealed in a vial for 24 hours before ethylene 
accumulation was measured. B) In addition to the aforementioned treatments, Arabidopsis 
seedlings were vacuumed-infiltrated with Pfo-1 expressing HopAF1H186A and Pfo-1 
expressing HopAF1G2AC4S. 3 hours after infiltration, the fresh weight of 4 seedlings was 
measured and these seedlings were sealed in a vial for 24 hours before ethylene 
accumulation was measured. Error bars represent standard error and an ANOVA was 
performed, followed by Tukey’s post-hoc analysis (p < 0.05). Groups that differ significantly 
are indicated with different letters. 
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Figure 3.13. Pfo-1 is unable to induce high levels of ethylene biosynthesis in Yang 
cycle mutants, mtn1 mtn2 and mtk. A) Seedlings of Col-0 and Arabidopsis mutants mtn1-
1, mtn1-2, mtn2-1, and mtn2-2, were vacuum-infiltrated with Pfo-1 carrying the empty vector 
(EV) or Pfo-1 expressing wild-type, native promoter HopAF1. 3 hours post infiltration, the 
fresh weight of 4 seedlings was measured and these seedlings were sealed in a vial for 24 
hours before ethylene accumulation was measured. B) Seedlings of Col-0 and Arabidopsis 
mutants mtn1-2 mtn2-2 and mtk were vacuum-infiltrated with either MgCl2, Pfo-1 carrying 
the empty vector (EV) or Pfo-1 expressing wild-type, native promoter HopAF1. 3 hours post 
infiltration, the fresh weight of 4 seedlings was measured and these seedlings were sealed 
in a vial for 24 hours before ethylene accumulation was measured. Error bars represent 
standard error and an ANOVA was performed, followed by Tukey’s post-hoc analysis (p < 
0.05). Groups that differ significantly are indicated with different letters. 
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Figure 3.14. HopAF1 domain architecture and circular dichroism spectra of HopAF1, 
HopAF1H186A, and MTN1. A) Schematic of HopAF1 predicted domains and the truncations 
generated for in vitro analyses. B) Circular dichroism spectra collected at 25°C at the far-UV 
CD spectrum (185 nm to 260 nm) demonstrates that wild-type MTN1, 6xHis-HopAF1 and 
6xHis-HopAF1H186A have secondary structure. The H186A mutation in HopAF1 does not 
perturb the secondary structure. The buffer control (20 mM sodium phosphate pH 7.4, 150 
mM NaF) was set as the baseline and subtracted from the protein-associated spectra 
above.  
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Figure 3.15. HopAF1 inhibits MTN1 activity in vitro in a manner dependent on catalytic 
activity. A) Michaelis-Menten plot of MTN1 activity measured in vitro using a xanthine 
oxidase-coupled spectrometric assay. Recombinant MTN1 was incubated for 18 hours in 
buffer at 37°C alone or with equimolar amounts of recombinant wild-type 6xHis-HopAF1 or 
GST.  B) MTN1 enzyme specific activity measured in vitro using xanthine oxidase-coupled 
spectrometric assay. MTN1 was incubated at 37°C for 18 hours with equimolar amounts of 
6xHis-HopAF1, 6xHis-HopAF1 H186A, ∆147-HopAF1, ∆130-HopAF1, and GST. Error bars 
represent standard error and an ANOVA was performed, followed by Tukey’s post-hoc 
analysis (p < 0.05). Groups that differ significantly are indicated with different letters. 
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Figure 3.16. The Yang cycle is required for PTI in Arabidopsis. Bacterial growth of 
P.syringae pv. tomato DC3000D28E (Cunnac et al., 2011) in Col-0, mtn1 mtn2, mtk, and 
ein2 was measured 0 and 3 days after hand inoculation with 1x105 cfu (colony-forming 
units)/mL bacteria. Error bars represent standard error (SEM). An analysis of variance 
(ANOVA) was performed among the day 3 samples, followed by Tukey’s post-hoc analysis 
(p < 0.05). Groups that differ significantly are indicated with different letters.   
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Figure 3.17. Proposed model of HopAF1 suppression of plant innate immunity. Plant 
pathogens such as P. syringae and X. campestris inject multiple type III effector (T3E) 
proteins into plant cells, including HopAF1 and AvrXv3, respectively. Recognition of PAMPs, 
such as flg22, a peptide derived from bacterial flagellin, by pattern-recognition receptors 
(PRRs) such as FLS2 triggers a signal cascade that results in a multiple of outputs, which 
we collectively call PTI for PAMP-triggered immunity. Additionally, recognition of T3Es by 
plant Resistance proteins, often called NLRs, triggers ETI. The hypersensitive response 
(HR) is often associated with ETI. Through perception of flg22 and activation of a MAPK 
cascade, PTI leads to an increase in ethylene biosynthesis. Our data suggests that HopAF1 
inhibits PTI, including flg22-induced PTI. Our model predicts that HopAF1 is targeted to the 
plant plasma membrane via acylation, where it inhibits the function of Yang cycle proteins, 
MTN1 and MTN2, which are required for the induced level of ethylene that occurs during 
PTI. As a result, the induced amount of ethylene that occurs during PTI may be an important 
output, making the Yang cycle an important component of the plant defense pathway and 
HopAF1 a critical T3E that prevents high ethylene accumulation during the plant defense 
response by targeting the Yang cycle. Since we have confirmed that HopAF1 requires the 
putative catalytic residues, H186 and C159, for these functions, future work will include 
determining the molecular mechanism by which HopAF1 inhibits MTN activity and how this 
potential modification translates into a loss-of-function phenotype for Arabidopsis MTNs.  
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 Chapter 4 
Conclusions and Future Directions 
Many plant bacterial pathogens use type III effectors (T3Es) as their main virulence 
determinants (Deslandes and Rivas, 2012). The type III secretion system is essential to the 
ability of these plant pathogens to cause disease on their hosts. As such, it is critical to 
understand which host cellular systems T3Es are targeting and how they are disrupting 
those systems. Much progress has been made in this field during the course of my graduate 
career. Because T3Es can be used as probes of the plant immune system, the knowledge 
of which plant cellular systems T3Es disrupt can be used to decipher ways to make the 
plants more resistant to pathogen attack. Additionally, we learn how these potent virulence 
factors, which are common in plant and animal pathogens, function. Although recently 
several functions and targets for T3Es have been identified, the sheer number of plant 
pathogen T3Es ensures that there is still a lot of work to be done.  
In Chapter 3, I presented research that describes the function of a conserved type III 
effector, HopAF1, and I noted how it contributes to disease in Arabidopsis. HopAF1 inhibits 
the function of Yang cycle proteins, MTN1 and MTN2. This prevents the induction of 
ethylene biosynthesis that occurs during the plant immune response after the perception of 
PAMPs (termed PTI). The result is that HopAF1 inhibits a component of PTI, leading to 
enhanced growth of weakened strains of P. syringae.  
The research described in Chapter 3 is the beginning of our efforts to fully elucidate 
the function of HopAF1 and the specific effect that it has on Arabidopsis MTN proteins. 
Although we have predicted, based on structural modeling, that HopAF1 is a member of the 
family of bacterial toxins/effectors that are deamidases (Washington et al., 2013), we have 
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not yet demonstrated that HopAF1 activity leads to deamidation of Arabidopsis MTNs or any 
other proteins. We have, however, demonstrated that the ability of HopAF1 to block PTI, 
inhibit MTN1 function in vitro, and inhibit PAMP-induced ethylene biosynthesis is dependent 
on putative catalytic residues. Therefore, we demonstrated that HopAF1 has enzymatic 
activity.  
In this chapter, I will discuss the future directions to significantly extend this work, 
which include determining the specific biochemical effect of HopAF1 on MTN1, solving the 
HopAF1 and MTN1 co-crystal structure, and using the Yang cycle to increase plant 
resistance to pathogen attack.  
Using a shotgun approach and mass spectrometry to determine if HopAF1 
modulates MTN function via deamidation. 
Bacterial virulence factor deamidases typically alter a single conserved residue to 
modulate target protein function (Washington et al., 2013). Thus, we sought to identify 
conserved Arabidopsis MTN asparagine and glutamine residues that conferred loss-of-
function phenotypes when mutated to the ‘deamidated’ residues, aspartic acid and glutamic 
acid, respectively. We discovered only three fully conserved residues across the 
evolutionary distance between plants and E. coli that could be targets of putative 
deamidases: MTN1N113, MTN1N169, and MTN1N194 (Figure 4.1). Since the crystal structures of 
Arabidopsis MTN1 and MTN2 are solved, we determined where the putative deamidation 
target residues are in relation to the MTN ligand binding site and catalytic residues. 
MTN1N113 is involved in ligand binding via coordination of a water molecule in the ligand 
binding pocket. MTN1N194 and MTN1N169 are both surface-exposed and at the end of helices 
α4 and α3, respectively (Figure 4.1). These conserved residues are located in approximately 
the same place in the MTN2 crystal structure.  
We generated individual deamidation mimic MTN1 variants (MTN1N113D, MTN1N169D, 
and MTN1N194D) and tested their function using an assay to measure MTN activity in vitro 
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(Dunn et al., 1994). For negative controls, we also cloned and purified MTN1D225N and 
MTN2D212N, catalytic residue loss-of-function alleles (Bretes et al., 2011). We determined 
that both MTN1N113D and MTN1N194D lost activity in vitro, while MTN1N169D retained wild-type 
levels of activity (Figure 4.2). Circular dichroism spectra confirmed that all of the MTN1 
deamidation mimic variants retain elements of secondary structure, similar to wild-type 
MTN1 (Figure 4.3). 
We also determined whether the loss-of-function phenotypes we noted above are 
dependent on the introduction of a negative charge in the deamidation mimics. The 
MTN1N194A and MTN1N194V variants retained wild-type levels of activity (Figure 4.2). This 
suggests that a charge change at MTN1N194, as would occur during deamidation, causes a 
loss-of-function phenotype but that conservative replacement at MTN1N194 does not alter 
activity. Conversely, MTN1N113A and MTN1N113V resulted in loss-of-function (Figure 4.2), 
suggesting that MTN1N113 is sensitive to multiple mutations. This is consistent with the idea 
that MTN1N113 is involved in ligand binding. We generated the same set of variants for 
Arabidopsis MTN2 and determined that they functioned similar to MTN1 (Figure 4.2).  
Based on the results using our deamidation mimics of MTN1 and MTN2, we 
hypothesize that HopAF1 targets MTN1N113, MTN1N194, or both. Mass spectrometry can be a 
critical tool for identifying specific residues that are modified via posttranslational 
modifications (Witze et al., 2007). As such, mass spectrometry has been used to identify a 
single residue on each target protein that is deamidated by known bacterial deamidase 
toxins (Washington et al., 2013). Our initial attempts to identify MTN residues deamidated by 
HopAF1 via mass spectrometry resulted in a general identification of nonenzymatically 
deamidated residues (not shown). Nonenzymatic deamidation is a natural process that 
occurs as proteins age, leading to their eventually misfolding and degradation. We 
concluded that mutated residues identified in our original mass spectrometry experiments 
were a result of nonenzymatic deamidation because multiple MTN residues were 
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deamidated after no treatment, treatment with HopAF1, and treatment with catalytic dead 
HopAF1.  
As an alternative, we will generate peptides containing the residues described above 
and incubate them with HopAF1. Although, deamidation of peptides derived from a target 
protein has not been demonstrated using mass spectrometry, Lerm et al. demonstrated that 
CNF1 can deamidate a peptide derived from RhoA residues 59-78 using the glutamate 
dehydrogenase assay (Lerm et al., 1999). It was also demonstrated that CNF1 could 
deamidate a peptide derived from RhoA residues 59-69. Deamidation was evident due to 
increased elution times on a C18 hydrophobic column (Flatau et al., 2000). After incubating 
HopAF1 with the peptides derived from MTN1, we will use a hydrophobic column to purify 
the peptides and analyze them using mass spectrometry. We will be able to determine 
whether the putative target residues have been converted to aspartic acids. We will also 
attempt to detect deamidation of peptides generated from recombinant wild-type MTN1 
protein. These peptides may allow us to detect the modification of residues not considered 
in our shotgun approach.  
Determine whether a functional deamidation site variant of MTN1 is impervious to 
HopAF1 activity in planta.  
We demonstrated above that deamidation mimics MTN1N113D and MTN1N194D lose 
enzymatic activity in vitro. We also showed that MTN1N194A and MTN1N194V retain activity. We 
are currently performing in planta complementation experiments using ubiquitin promoter 
driven constructs of wild-type MTN1, MTN1N194D, MTN N194V, MTN1N113D, MTN1N113V, and 
MTN1D225N transformed into the mtn1 mtn2 double mutant. This double mutant is viable, but 
fails to set seed (Burstenbinder et al., 2010). It has previously been demonstrated that a 
ubiquitin promoter-driven MTN1 can complement the mtn1 mtn2 infertility phenotype 
(Waduwara-Jayabahu et al., 2012). We will first address whether each of our constructs can 
complement the loss of seed set phenotype. Based on the results of our in vitro assays 
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described above, we hypothesize that MTN1 wild-type and MTN1N194V will complement the 
loss of seed set phenotype because these are functional variants, but that the deamidation 
mimic MTN1N194D will not. Similarly, we expect the MTN1N113D and MTN1D225N 
complementation lines to remain infertile because MTN1N113D and MTN1D225N are loss-of-
function variants involved in ligand binding and catalysis, respectively.  
We will then repeat our experiment to measure PAMP-induced ethylene biosynthesis 
in transgenic seedlings expressing each MTN1 variant. If our hypothesis is true, we expect 
that MTN1 wild-type and MTN1N194V will support PAMP-dependent ethylene formation, but 
that MTN1N194D will not. We also expect that HopAF1 delivery will suppress Pfo-1-induced 
ethylene production in plants expressing wild-type MTN1. The key test will be whether or not 
MTN1N194V, which we hypothesize will still be functional based on our MTN activity 
determination (see Figure 4.2 above), will be unaffected by HopAF1. If so, we will conclude 
that MTN1N194 is the sole site of action for HopAF1. 
In Chapter 3, we demonstrate that the mtn1 mtn2 double mutant is more susceptible 
to weakened Pto DC3000D28E compared to Col-0 wild-type. We will determine the 
susceptibility of mtn1 mtn2 plants to Pto DC3000D28E expressing wild-type HopAF1 under 
a native promoter with a C-terminal HA tag. If Pto DC3000D28E(HopAF1) grows to equal 
levels in Col-0 as Pto DC3000D28E does in mtn1 mtn2 and there is no further increase in 
growth of Pto DC3000D28E(HopAF1) on mtn1 mtn2 plants, this will indicate the MTN1 and 
MTN2 are necessary for the HopAF1-mediated increase in the growth ofDC3000D28E that 
we described in Chapter 3.   
Furthermore, we will determine the ability of Pto DC3000D28E and Pto 
DC3000D28E(HopAF1) to grow in the mtn1 mtn2 complementation lines in which we 
express either wild-type MTN1, MTN1N194V, MTN1N194D, MTN1N113D, MTN1N113V or MTN1D225N 
under the ubiquitin promoter. Complementing mtn1 mtn2 with non-functional variants of 
MTN1, such as MTN1N194D and MTN1N113D will likely result in plants in which both Pto 
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DC3000D28E and Pto DC3000D28E(HopAF1) grow to an equally high titer. However, since 
MTN1N194V is functional and no longer a target of the putative deamidation activity of 
HopAF1, we expect MTN1N194V to be blind to HopAF1 and therefore to not be susceptible to 
either Pto DC3000D28E or Pto DC3000D28E(HopAF1). This result will further confirm that 
the ability of HopAF1 to inhibit PTI is dependent upon modification of Arabidopsis MTN1N194.  
Generate a HopAF1/MTN1 co-crystal to determine the molecular mechanism 
behind HopAF1 inhibition of MTN activity.  
The generation of co-crystals of bacterial deamidases and their targets addresses 
the critical question of how deamidases can modulate target protein activity (Crow et al., 
2012; Fu et al., 2013; Yao et al., 2012). This will also provide information on how target 
proteins function, which is highly relevant for several known deamidase targets such as 
RhoA, ubiquitin, NEDD8, and Gα proteins (Cui et al., 2010; Flatau et al., 1997; Orth et al., 
2009; Schmidt et al., 1997). It is equally important to understand how plant 
methylthioadenosine nucleosidases function, as these proteins are involved in recycling 
methionine, the precursor for protein translation, polyamine biosynthesis, and ethylene 
biosynthesis.  
Using published methods (Park et al., 2006), we are able to purify MTN1 from E. coli. 
We generated an expression construct using the Gateway-compatible pDEST15 vector 
(Gateway, Invitrogen). This vector includes an IPTG-inducible promoter with an N-terminal 
GST tag. We cloned a PreScission Protease (GE Healthcare) cleavage site between the 
GST tag and MTN1 to allow for specific and efficient cleavage at 4°C. We used affinity 
chromatography to separate GST-tagged MTN1 from the crude lysate. Then we cleaved 
used PreScission Protease to cleave the protein and used reverse affinity to 
chromatography to capture ‘free’ MTN1 in the flow-through. This protein was approximately 
90% pure (Figure 4.4). To increase the purity of MTN1 for the purposes of crystallization, we 
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will run the partially purified protein over a size exclusion column. This will also determine if 
the protein is folded and monodispersed. 
After attempting many methods, we have made significant progress in optimizing the 
purification of HopAF1. We used a disorder prediction program, RONN, which revealed that 
the N-terminus of HopAF1 contains regions of disorder (Yang et al., 2005). These regions of 
disorder may likely make it difficult to purify large quantities of full-length HopAF1 and may 
also inhibit crystal formation in the future. Again using Gateway technology, we cloned a 
6xHis-MBP (maltose-binding protein) on the N-terminus of HopAF1 truncations and we 
identified the minimal region of HopAF1 required for activity (see Figure 3.14 and Figure 
3.15 in Chapter 3). 6xHisMBP-∆55HopAF1 was insoluble, while 6xHis-∆147HopAF1 was 
not able to inhibit MTN activity in vitro. However, purification of 6xHis-∆130HopAF1, the 
residues of HopAF1 that correspond to the putative catalytic domain, was successful (Figure 
4.5) and ∆130HopAF1 can inhibit MTN1 activity (see Figure 3.15 in Chapter 3). Therefore, 
we decided to focus on purifying ∆130HopAF1 for crystallography studies.  
 Our current protocol, similar to the purification scheme of MTN1, uses affinity 
chromatography was used to capture 6xHisMBP-∆130HopAF1 from crude extract (figure 
5A). Then after cleavage with TEV protease, reverse affinity chromatography was used to 
capture ∆130HopAF1 in the flow-through (Figure 4.5B). Finally, ∆130HopAF1 was run over 
a size exclusion chromatography column, resulting in a monodispersed peak (Figure 4.5C). 
Interestingly, the ∆30HopAF1 monodispersed peak elution time suggests that the protein is 
forming oligomers. We will perform size exclusion chromatography multi-angle light 
scattering (SEC-MALS) experiments in the UNC Macromolecular Interactions Facility to 
determine the nature of these oligomers.      
To start the crystallization trials, we will first confirm that HopAF1 and MTN1 form a 
stable complex in solution using size exclusion chromatography. Since the crystal structure 
of MTN1 from Arabidopsis has been solved (Park et al., 2006), we will start with the 
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conditions used for MTN1 and begin the crystallization trials with HopAF1/MTN1 in the UNC 
Protein Crystallography core facility.  
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Figures 
 
Figure 4.1. Alignment and structural localization of MTN1 conserved putative 
deamidase target residues. A) Alignment of methylthioadenosine nucleosidase amino acid 
sequences from plants and E. coli. B) Ribbon representation of the MTN1 crystal structure 
(PDB 2H8G).  Monomers are represented in sand and silver. The ligand analog (MTT) is 
shown in green. The ligand-binding and catalytic residues from MTN1 are represented as 
blue sticks. The putative conserved targets of deamidation are labeled and colored as red 
stick representations. Images were generated using Pymol.  
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Figure 4.2. MTN1 and MTN2 variants display loss-of-function phenotypes when 
residues N113 and N194 are ‘deamidated’. A) MTN1 enzyme specific activity measured in 
vitro using xanthine oxidase-coupled spectrometric assay. MTN1 catalytic dead mutant is 
MTN1D225N. B) MTN2 enzyme specific activity measured in vitro using xanthine-oxidase 
coupled spectrometric assay. MTN2 catalytic dead mutant is MTN2D212N. Letters represent 
treatments with significant difference according to the post-hoc ANOVA Tukey’s test (p < 
0.05). 
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Figure 4.3. Circular dichroism spectra of MTN1 ‘deamidated’ variants does not vary 
from wild-type MTN1. Circular dichroism spectra were recorded for MTN1 variants in 20 
mM sodium phosphate buffer pH 7.4, 150 mM NaF from 185 nm to 260 nm. The differential 
spectrum was obtained by subtracting the buffer spectrum before conversion to molar 
ellipticity.  
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Figure 4.4. Purification of wild-type MTN1. A) The construct used to purify MTN1 consists 
of an N-terminal glutathione S-transferase (GST) tag, followed by a PreScission Protease 
cleavage site (PP), and the coding sequence of Arabidopsis MTN1 (At4g38800). B) SDS-
PAGE analysis and Coomassie stain of affinity purification using the GST tag. Fractions 13-
17 represent the eluted fractions that contain full-length GST-PP-MTN1. C)  SDS-PAGE 
analysis and Coomassie stain of MTN1 after cleavage with PreScission Protease to remove 
the GST tag. The cleaved protein was run over a fresh GST affinity column to capture the 
GST and PreScission Protease, allowing MTN1 to be collected in the flow through fractions. 
Black arrows denote the proteins of interest from each step of the purification.  
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Figure 4.5. Purification of ∆130 HopAF1. A) The construct used to purify ∆130-HopAF1 
consists of an N-terminal 6xHis-Maltose Binding Protein (MBP) tag, followed by a TEV 
Protease cleavage site (TEV), and the coding sequence of P. syringae pv. tomato DC3000 
HopAF1. B) SDS-PAGE analysis and Coomassie stain of affinity purification using the 6xHis 
tag. The eluted fractions contain full-length 6xHisMBP-TEV-∆130HopAF1. C)  SDS-PAGE 
analysis on a 15% gel and Coomassie stain of ∆130HopAF1 after cleavage with TEV 
Protease to remove the 6xHisMBP tag. The cleaved protein was run over a fresh His affinity 
column to capture the 6xHisMBP and TEV Protease, allowing ∆130HopAF1 to be collected 
in the flow through fractions. D) ∆130HopAF1 was run over a size exclusion column 
resulting in a monodispersed elution of protein.  Black arrows denote the proteins of interest 
from each step of the purification.  
  
155 
REFERENCES 
Bretes, E., Guranowski, A., and Nuc, K. (2011). 5'-methylthioadenosine nucleosidase from 
yellow lupine (Lupinus luteus): molecular characterization and mutational analysis. 
Protein and peptide letters 18, 817-824. 
Burstenbinder, K., Waduwara, I., Schoor, S., Moffatt, B.A., Wirtz, M., Minocha, S.C., 
Oppermann, Y., Bouchereau, A., Hell, R., and Sauter, M. (2010). Inhibition of 5'-
methylthioadenosine metabolism in the Yang cycle alters polyamine levels, and 
impairs seedling growth and reproduction in Arabidopsis. The Plant journal : for cell 
and molecular biology 62, 977-988. 
Crow, A., Hughes, R.K., Taieb, F., Oswald, E., and Banfield, M.J. (2012). The molecular 
basis of ubiquitin-like protein NEDD8 deamidation by the bacterial effector protein 
Cif. Proceedings of the National Academy of Sciences of the United States of 
America 109, E1830-1838. 
Cui, J., Yao, Q., Li, S., Ding, X., Lu, Q., Mao, H., Liu, L., Zheng, N., Chen, S., and Shao, F. 
(2010). Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a 
bacterial effector family. Science 329, 1215-1218. 
Deslandes, L., and Rivas, S. (2012). Catch me if you can: bacterial effectors and plant 
targets. Trends in plant science 17, 644-655. 
Dunn, S.M., Bryant, J.A., and Kerr, M.W. (1994). A simple spectrophotometric assay for 
plant 5′-deoxy-5′-methylthioadenosine nucleosidase using xanthine oxidase as a 
coupling enzyme. Phytochemical Analysis 5, 286. 
Flatau, G., Landraud, L., Boquet, P., Bruzzone, M., and Munro, P. (2000). Deamidation of 
RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of 
the GTPase switch 2 domain. Biochemical and biophysical research communications 
267, 588-592. 
Flatau, G., Lemichez, E., Gauthier, M., Chardin, P., Paris, S., Fiorentini, C., and Boquet, P. 
(1997). Toxin-induced activation of the G protein p21 Rho by deamidation of 
glutamine. Nature 387, 729-733. 
Fu, P., Zhang, X., Jin, M., Xu, L., Wang, C., Xia, Z., and Zhu, Y. (2013). Complex Structure 
of OspI and Ubc13: The Molecular Basis of Ubc13 Deamidation and Convergence of 
Bacterial and Host E2 Recognition. PLoS pathogens 9, e1003322. 
Lerm, M., Selzer, J., Hoffmeyer, A., Rapp, U.R., Aktories, K., and Schmidt, G. (1999). 
Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: 
156 
activation of c-Jun N-terminal kinase in HeLa cells. Infection and immunity 67, 496-
503. 
Orth, J.H., Preuss, I., Fester, I., Schlosser, A., Wilson, B.A., and Aktories, K. (2009). 
Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. 
Proceedings of the National Academy of Sciences of the United States of America 
106, 7179-7184. 
Park, E.Y., Oh, S.I., Nam, M.J., Shin, J.S., Kim, K.N., and Song, H.K. (2006). Crystal 
structure of 5'-methylthioadenosine nucleosidase from Arabidopsis thaliana at 1.5-A 
resolution. Proteins 65, 519-523. 
Schmidt, G., Sehr, P., Wilm, M., Selzer, J., Mann, M., and Aktories, K. (1997). Gln 63 of Rho 
is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387, 725-
729. 
Waduwara-Jayabahu, I., Oppermann, Y., Wirtz, M., Hull, Z.T., Schoor, S., Plotnikov, A.N., 
Hell, R., Sauter, M., and Moffatt, B.A. (2012). Recycling of methylthioadenosine is 
essential for normal vascular development and reproduction in Arabidopsis. Plant 
physiology 158, 1728-1744. 
Washington, E.J., Banfield, M.J., and Dangl, J.L. (2013). What a Difference a Dalton Makes: 
Bacterial Virulence Factors Modulate Eukaryotic Host Cell Signaling Systems via 
Deamidation. Microbiology and molecular biology reviews : MMBR 77, 527-539. 
Witze, E.S., Old, W.M., Resing, K.A., and Ahn, N.G. (2007). Mapping protein post-
translational modifications with mass spectrometry. Nature methods 4, 798-806. 
Yang, Z.R., Thomson, R., McNeil, P., and Esnouf, R.M. (2005). RONN: the bio-basis 
function neural network technique applied to the detection of natively disordered 
regions in proteins. Bioinformatics 21, 3369-3376. 
Yao, Q., Cui, J., Wang, J., Li, T., Wan, X., Luo, T., Gong, Y.N., Xu, Y., Huang, N., and Shao, 
F. (2012). Structural mechanism of ubiquitin and NEDD8 deamidation catalyzed by 
bacterial effectors that induce macrophage-specific apoptosis. Proceedings of the 
National Academy of Sciences of the United States of America 109, 20395-20400. 
 
 
 
